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Zusammenfassung
Genexpression, d. h. die zellula¨re Synthese von Proteinen, setzt sich aus den Teilschritten
Transkription (mRNA Synthese auf Grundlage der DNS), Translation (Proteinsynthese
auf Grundlage der mRNA) und Proteinfaltung zusammen. Aufgrund der großen Zahl an
Wechselwirkungen einzelner Komponenten ist dieser Prozess in vivo sehr komplex, was
eine quantitative mathematische Modellierung extrem aufwendig macht. Indem auf ver-
einfachte in vitro Modellsysteme zuru¨ckgegriffen wird, ko¨nnen Teilaspekte der zellula¨ren
Genexpression im Detail studiert werden. Mit “zellfreier Genexpression” wird die bio-
chemische Synthese von Proteinen in vitro bezeichnet. Die dabei eingesetzten zellfreien
Systeme bestehen aus den Hauptbestandteilen der zellula¨ren Transkriptions- und Trans-
lationsmaschinerie wie Polymerasen, Ribosomen, Aminosa¨uren und Nukleotiden, gelo¨st in
Puffer. Diese Systeme werden entweder aus Zellextrakt gewonnen oder aus aufgereinigten
Einzelkomponenten komplett zusammengesetzt.
Im dieser Arbeit wurde Genexpression in einem zellfreien System genutzt, um ein
quantitatives Modellsystem der Genexpressionskinetik in vitro zu entwickeln. Zu diesem
Zweck wurden Techniken erarbeitet, die reproduzierbare quantitative Fluoreszenzmessun-
gen der zellfrei produzierten mRNA- und Proteinmenge erlauben. Hier wurde das gru¨n
fluoreszierende Protein GFP exprimiert, da es sowohl in prokaryotischen als auch in eu-
karyotischen Wirten produziert werden kann und durch seine Fluoreszenz nachweisbar ist.
Fu¨r den Nachweis der mRNA kamen spezifische molekulare Fluoreszenzmarker (molecu-
lar beacons) zum Einsatz. Basierend auf Messreihen der Kinetik von mRNA und GFP
Synthese wurde ein mathematisches Modell gewo¨hnlicher Differentialgleichungen entwick-
elt. Das Modell beru¨cksichtigt die Sa¨ttigung der zellfreien Genexpressionsmaschinerie bei
hohen DNS Konzentrationen sowie Verzehr und unspezifischen Abbau von Ressourcen im
Laufe der Synthesereaktion. Dadurch stimmen Daten und Modell bei simultaner Daten-
anpassung mit einem einzigen Satz von Parametern u¨ber fu¨nf Gro¨ßenordnungen der DNS
Konzentration und u¨ber den gesamten Verlauf der Kinetik sehr gut u¨berein. Dank seiner
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Vorhersagekraft ist das hier aufgestellte Modellsystem ein nu¨tzliches Werkzeug fu¨r Studien
zur Transkriptions- und Translationsmechanik, zu Regulationsnetzwerken und Modifika-
tionen einzelner Komponenten.
Im na¨chsten Schritt wurde untersucht, in wie weit der vorgestellte Ansatz auf ein Sys-
tem anwendbar ist, das einer natu¨rlichen Zelle sta¨rker a¨hnelt, na¨mlich mRNA bzw. DNS
transfizierten Zellen. Dabei zeigte sich, dass das Modell die Kinetik DNS transfizierter
Zellen nur dann zufriedenstellend wiedergeben kann, wenn die Modellparameter sehr stark
von Literaturwerten abweichen. Andererseits beschreibt das einfache Ratenmodell die
Kinetik mRNA transfizierter Zellen exakt. Das ko¨nnte ein Hinweis darauf sein, dass der
Transportprozess der synthetisierten mRNA vom Zellkern in das Zytoplasma einen bisher
unbekannten Einfluss auf den Verlauf der Genexpression hat. Mit Hilfe dieser Model-
lierung konnten die Degradationsraten von mRNA und GFP sehr exakt ermittelt werden.
Des Weiteren wurde ein stochastisches Modell adaptiert, mit welchem die Aufnahme der
mRNA durch eine Zelle wiedergegeben werden konnte, was eine Abscha¨tzung der mittleren
Anzahl an mRNA Moleku¨len pro transfizierter Zelle erlaubt.
Zellfreie Systeme eignen sich bestens, um die Auswirkung von modifizierten Kompo-
nenten auf die Expressionskinetik zu analysieren. Beispielsweise ist bekannt, dass D2O das
Zellwachstum hemmt, seine genaue Wirkung auf die Proteinsynthese ist aber noch nicht
vollsta¨ndig analysiert. D2O ist besonders dadurch interessant, dass es als kleine globale
Sto¨rung aller Teilschritte der Proteinsynthese betrachtet werden kann. Es zeigte sich, dass
Transkription, Translation und Proteinfaltung von D2O beeinflusst werden, allerdings in
unterschiedlichem Maße. Vergleichsmessungen mit E. coli zeigten, dass das ku¨nstliche
System sta¨rker auf D2O reagiert, als die wesentlich komplexeren lebenden Organismen.
Diese Erkenntnisse ko¨nnten ferner dabei helfen, den Ertrag von Genexpression in D2O zu
optimieren, was fu¨r die zellfreie Herstellung deuterierter Proteine fu¨r die Kernspinreso-
nanzspektroskopie bedeutsam ist.
Ein wichtiges Ziel der synthetischen Biologie ist die Konstruktion einer ku¨nstlichen min-
imalen Zelle. Eine Herangehensweise ist, zellfreies Extrakt in Lipidvesikeln einzuschließen.
Besonders bedeutsam ist hierbei, Transmembranproteine zu exprimieren und korrekt gefal-
tet in die ku¨nstliche Membran einzubauen. Dies ermo¨glicht z. B. den Na¨hrstoffaustausch
mit der Umgebung, oder erlaubt, definierte Bindungsstellen zu schaffen. Im Rahmen dieser
Arbeit wurde das Transmembranprotein Ephrin-B2 zellfrei exprimiert und in situ in Vesikel
eingebunden. Diese Methode kann ferner dazu genutzt werden, auf einem mikrostruktu-
rierten Substrat definierte Bindungsstellen fu¨r Zellen zu schaffen.
Summary
Genexpression that is the cellular synthesis of proteins is comprised of the sub-steps tran-
scription (mRNA synthesis based on the DNA master), translation (protein synthesis based
on the mRNA) and protein folding. Owing to the large number of interactions between
individual components this process is very complex in vivo and therefore mathematical
modeling is extremely laborious. By means of simplified in vitro model systems individ-
ual aspects of cellular gene expression can be studied in detail. Cell-free gene expression
denotes the biochemical synthesis of proteins in vitro. Cell-free systems are comprised of
the predominant components of the cellular transcription and translation machinery like
polymerases, ribosomes, amino acids and nucleotides dissolved in buffer. These systems
are either cellular extracts or are reconstituted from purified components.
In this thesis gene expression in a cell-free system was used to develop a quantitative
model system of the gene expression kinetics in vitro. To this end techniques were developed
that enable reproducible quantitative fluorescence measurements of mRNA and protein
synthesized in a cell-free system. Here, the green fluorescent protein GFP was used since
it can be expressed both in prokaryotic and eukaryotic hosts and it can be detected by
its fluorescence. In order to measure mRNA levels specific molecular fluorescence markers
(molecular beacons) were used. Based on measurements of the kinetics of mRNA and
GFP synthesis a mathematical model of ordinary differential equations was developed.
The model accounts for the saturation of the cell-free gene expression machinery at high
DNA concentrations as well as for the unspecific degradation of resources in the course
of the synthesis reaction. Thereby the model can concurrently fit the kinetics of mRNA
and GFP expression with one consistent set of parameters over five orders of magnitude of
DNA concentration. Due to its predictive power the model described here can be a valuable
tool for studies of transcription and translation mechanics, gene regulation networks and
modifications of individual components.
In the next step it was reassessed how well the modeling ansatz described here can be
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applied to a system that resembles a living cell more closely, that is to say mRNA and
pDNA transfected cells respectively. It was found that the model can satisfactorily fit the
kinetics of pDNA transfected cell only if model parameters far away from literature values
are used. On the other hand the simple model fits the kinetics of mRNA transfected cells
very well. This could indicate that the transport process of synthesized mRNA into the
cellular nucleus has an influence on the course of the protein synthesis that is so far not
exactly understood. By means of this model the degradation rates of mRNA and GFP
could be determined with great accuracy. Furthermore, a stochastic mRNA uptake model
was adapted which satisfactorily fits the transfection efficiency of mRNA vectors and allows
for an estimation of the number of mRNA molecules per transfected cell.
Cell-free systems are well suited for studying modifications of the gene expression ma-
chinery. For example, D2O impedes cellular growth and proliferation but its effect on
protein synthesis has not been ascertained in detail. D2O is furthermore interesting to
study because it can be viewed as a small global disturbance of all partial steps of gene
expression. It was found that all transcription, translation and protein folding are af-
fected by D2O albeit to varying grades. Comparison measurements with E. coli showed
that the artificial system reacts more strongly to D2O than the far more complex living
organism. These insights could further help to optimize the yield of protein expressed in
D2O which is important for the production of deuterated proteins for nuclear magnetic
resonance spectroscopy.
A major goal of synthetic biology is the development of an artificial minimal cell.
One approach to this is to encapsulate cell-free extract in lipid vesicles. In this regard it is
important to express transmembrane proteins and insert them into the artificial membrane
in their correctly folded state. This would for example allow for nutrient uptake or allow
to create defined binding sites. In this thesis the transmembrane protein ephrin-B2 was
expressed in a cell-free system and incorporated into vesicle membranes in situ. One
future application of this setup is the construction of defined cellular binding sites on a
microstructured substrate.
Chapter 1
Introduction
The 20th century brought an enormous increase of knowledge in all fields of science and
technology. This swift progress stems from an interplay between improved measurement
and analysis technologies and successive new scientific insights. Medicine and biology are
two fields that have especially profited from said progress. Over the course of only a
few decades the composition and functioning of living organisms were uncovered down to
the intra-cellular level. With the uncovering of more and more functions growing interest
arose about how all these functions are linked together. In other words one wants to know
all interactions of the components of an organism and how the totality of the individual
interactions gives rise to the behavior of the complete organism. This interdisciplinary
field of study has been termed “systems biology”. Two of the pioneers in this field were
the later Nobel Prize laureates Alan Lloyd Hodgkin and Andrew Fielding Huxley who
published a much-noticed mathematical model of neurons in 1952 [1]. However, systems
biology as a prominent field really took off not until the turn of the 21st century. At
this time large amounts of data on genomics and proteomics became available and the
increased computing power and broad adoption of the Internet allowed to exploit these
data. However, the goal to fully understand the regulation network of a single cell – let
alone a whole organism – is complicated by the immense complexity of the interactions. In
this connection the complementary engineering based approach of “synthetic biology” may
help to further our understanding. Synthetic biology just like systems biology is a recent
interdisciplinary field of study. It pursues the creation of artificial biological functions not
found in nature. Synthetic biology aims to reverse engineer natural systems, to build new
systems that do not already exist and to equip existing organisms with new functionalities.
Artificial analogies of organisms with their reduced complexity can also be used as model
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systems to test and refine systems biology models. This approach is often highlighted with
Richard Feynman’s famous quote “What I cannot create, I do not understand”.
A prominent goal of synthetic biology efforts is to create a minimal cell, that is a con-
struct which mimics natural cellular behavior up to self replication. To this end model
systems for the individual components that make up a living cell like molecular motors,
cellular membranes, encapsulation techniques and dynamic pattern formation are being
investigated [2, 3]. A further cellular component which is intensely studied is gene regula-
tion. Elowitz and Leibler constructed a synthetic transcription regulation network termed
the “repressilator” that exhibits mutual negative regulation. Inserted into E. coli the sys-
tem oscillated with periods longer than the cell cycle, which means the cellular state was
transmitted to the next generation [4]. The authors also observed noisy behavior which
can be attributed to stochasticity of the system’s components. In this pioneering work
the synthetic system was still incorporated into a natural host. The next logical step is to
create a completely artificial framework and this can be achieved by using so called cell-free
systems.
Cell-free systems denote mixtures of resources and enzymes that can be used to syn-
thesize protein from a DNA template in vitro. Although these systems were originally
developed for (compared to cell cultures) quick and easy to handle protein synthesis they
have become a prominent tool in synthetic biology applications. Noireaux et al. devel-
oped a genetic circuit exhibiting transcriptional activation and repression cascades in a
cell-free system [5]. The protein produced in one stage of their circuit serves as activator
or repressor of the next stage.
In order to bring this approach closer to the goal of creating a minimal cell it is necessary
to enclose the cell-free system with an artificial barrier that mimics the cellular membrane.
Vesicles made of artificial phospholipid bilayers are a promising model system since phos-
pholipids are the main ingredient of cellular membranes (the other is membrane proteins).
Preparation techniques exploit the self-organization property of the amphiphilic molecules
into bilayer vesicles in aqueous solutions [6]. However, these techniques are usually time
consuming and may not be compatible with even medium level ion concentrations. This is
problematic since it is desirable to capture also the early phase of gene expression which
requires a fast loading mechanism of cell-free system solution into the vesicles. Furthermore
cell-free extracts contain various species of ions. Noireaux and Libchaber developed a new
vesicle formation technique that fulfills these requirements. Droplets of cell-free extract
in oil form an emulsion with phospholipids forming a monolayer at the interface. These
3droplets are then spun down into buffer and lipids at the oil-buffer interface interact with
the monolayer around the droplets to form a bilayer. The authors then observe synthesis of
green fluorescent protein (GFP) inside the vesicles. They brought their concept even closer
to the goal of a minimal cell by expressing a second protein, namely the transmembrane
protein α-hemolysin in their vesicles. They showed that α-hemolysin successfully incor-
porated into the vesicle membrane and formed pores through which nutrients could pass
into the vesicle. This way the life-time of the gene expression reaction in the vesicles was
increased up to four days [7, 8]. Membrane proteins are challenging to synthesize as they
tend to aggregate in aqueous solutions and therefore require the application of detergents.
However, as mentioned above cell-free synthesized membrane proteins can incorporate into
artificial lipid membranes in situ. Apart from α-hemolysin this has also been demonstrated
for a number of other membrane proteins [9–12]. Furthermore, Dittrich et al. developed
a microfluidics setup which creates an emulsion of micro-droplets of cell-free system in
oil [13]. These droplets are very stable, monodisperse and can be produced with a high
throughput of up to 30 droplets per second.
A different approach is to fabricate micro compartments directly in a microfluidics
chip [14–17]. In combination with a sophisticated system of channels and valves such
microarrays can be used for example for high throughput proteomics studies [18, 19].
Cell-free systems are usually a mixture of cell lysate and some added components and
therefore their composition is not entirely known. However, recently a cell-free system was
presented that is comprised solely of purified components [20, 21]. Such a reconstituted
system guarantees that no interference due to unknown and unwanted components will
distort the outcome of an experiment.
The aim of this thesis was to establish a cell-free system as a model system for studying
gene expression in vitro. In order to do so experimental and theoretical tools were devel-
oped that permit quantitative conclusions from experimental data. The results of the in
vitro model were compared to gene expression kinetics in living cells. Subsequently the
established knowledge of the particular cell-free system was used to examine how exactly
an agent (here deuterated water) modifies the individual kinetic rates. Lastly an extension
of the experimental procedure is presented with which a membrane protein could be shown
to be synthesized and incorporated into artificial lipid membranes.
This thesis is arranged as follows: in chapter 2 basic theoretical concepts are presented.
A short description of the individual steps and necessary components of the gene expression
mechanism is given. This is followed by an overview over the history, composition and
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different experimental setups of cell-free gene expression systems. Subsequently GFP which
was used as fluorescent probe is briefly introduced. Furthermore the differences in physical
properties of deuterated water in comparison to normal water are presented.
In chapter 3 the experimental protocols for sample preparation, measurement proce-
dure and data analysis are explained in detail. Fluorescent microscopy and fluorescence
correlation spectroscopy are briefly presented. Special focus is given to the description of
the developed calibration standard for quantitative GFP fluorescence measurements.
In chapter 4 a mathematic model of cell-free gene expression kinetics based on differ-
ential equations for individual kinetics rates is presented. A Michaelis-Menten like ansatz
was incorporated into the model to account for different template DNA concentrations.
Furthermore, the model assumes finite pools of resources for transcription and translation
to account for the observed cessation of in vitro protein synthesis after a fixed time. This
way cell-free gene expression kinetics could be fitted from the early to the late phase and
this over five orders of magnitude of DNA concentration. It was found that the translation
step is the bottle neck in GFP synthesis and that already terminated cell-free expression
could be restarted by introducing fresh ribosomes into the system. These findings could
help to improve yield strategies in cell-free protein synthesis. This properly characterized
cell-free system in combination with the predictive model presented here is a valuable tool
for studies on transcription and translation kinetics or on in vitro gene regulation networks.
In chapter 5 the kinetic rate based modeling approach is applied to a system that is
more closely alike a living cell: DNA and mRNA transfected cells respectively. The kinet-
ics of mRNA but not pDNA transfected cells could be rigorously modeled with this basic
approach. Distributions for the mRNA and GFP degradation rates as well as number
of mRNA molecules taken up by a cell were derived. Assuming that mRNA is taken up
and released in statistically independent quanta (the lipoplexes used for transfection), the
average number of mRNAs per lipoplex could be estimated. Interestingly, kinetics of DNA
transfected cells could not be fitted adequately, probably hinting at some cooperativity
effect in vivo that is so far not understood. This work demonstrates that mRNA transfec-
tion in combination with computer modeling can be a powerful tool for time-resolved gene
expression studies for example of siRNA knockdown.
In chapter 6 a cell-free system is used to study how the influence of deuterated water on
gene expression also observed in vivo affects the individual rates: transcription, translation
and maturation. It was found that D2O affects individual polymerase differently. With
a prokaryotic DNA polymerase an inhibitory effect was found whereas with a viral RNA
5polymerase D2O was observed to amplify the synthesis efficiency. Interestingly, the D2O
effect was less pronounced in vivo although gene expression in a living organism is much
more complex. The results presented could help to improve yield strategies for the cell-free
synthesis of deuterated proteins which is necessary for nuclear magnetic resonance studies
of protein structures.
Chapter 7 covers the cell-free synthesis of a transmembrane protein (ephrin-B2) and its
in situ incorporation into a model membrane. Furthermore, it is shown how microstruc-
tured substrates can be used to induce alignment and deformation of coexisting lipid phases
in substrate adhering artificial membranes. With membrane proteins that exhibit a pref-
erence for one lipid phase such a system could be used to create a substrate with defined
cellular binding sites for automated microscopy studies.
Finally chapter 8 gives an outlook to possible future applications of this thesis’ findings
as well as new questions that have arisen and need to be answered.
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Chapter 2
Basic concepts
2.1 Cell-free gene expression
2.1.1 The course of gene expression
Living cells come in many different shapes and sizes depending on the respective organism
and the cell’s individual task. However, even the most simple cell is made up of a highly
complex composition of ingredients like DNA, RNAs, energy sources, ions, proteins or
organelles (Fig. 2.1 A). This composition has to be constantly monitored and adapted
by feedback mechanisms so that the cell stays functional. This is especially true for the
composition of the proteins. In order to synthesize new proteins or replenish degraded ones
the cell accesses its ”long term memory”, namely its DNA. The demand for the production
of a certain type of protein produces a signal which activates the gene encoding this protein.
Depending on the specific regulatory motif of the gene there are different ways how this
activation step works (for a review on transcription regulation see [22, 23]). The next
steps are what Francis Crick, one of the co-discoverers of the double helix structure of the
DNA, called the “central dogma of molecular biology” [24]: DNA is transcribed into RNA
which in turn is translated into a protein. This is a one-way process, information is not
communicated from proteins to DNA (Fig. 2.1 B).
Transcription The process of transcribing the genetic information carried by the DNA
into RNA is basically the same for prokaryotic and eukaryotic organisms.1 Activation of
1Prokaryotes are bacteria and archaea. They have no cellular nucleus, their DNA swims in the cytoplasm
and takes the form of a ring. Eukaryotes (some unicellular organisms and almost all known multi-cellular
organisms) have a nucleus which houses their DNA. Their DNA takes the form of strongly condensed
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Figure 2.1: A) Some of the major components that make up an eukaryotic cell. B) The
“central dogma of molecular biology”: DNA is transcribed into mRNA by RNA polymerase
and mRNA is translated into a polypeptide chain by a ribosome. The polypeptide then
folds into a functional ribosome. This picture is greatly simplified, only the core compo-
nents are shown. In nature a great variety of additional components is necessary in order
to synthesize the multitude of different proteins that are contained in a cell.
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a gene means that the enzyme RNA-polymerase can now bind to a specific binding site
at the start of the gene, the promoter, and begin reading it. In doing so the polymerase
separates the DNA double helix by breaking the hydrogen bonds between the strands and
adds complementary RNA nucleotides to the coding strand. Then the sugar-phosphate
backbone of the RNA is formed, the DNA-RNA hydrogen bonds are broken and the RNA
separates from the DNA. At the end of the gene, the terminator, the polymerase is released
from the DNA. RNA differs from DNA in the fact that it is single stranded, contains ribose
instead of deoxyribose in its backbone and the nucleotide thymine is replaced by uracil.
A major difference between eukaryotes and prokaryotes is that in eukaryotes transcription
takes place in the nucleus (which prokaryotes lack) and the RNA is then transported into
the cytoplasm for further use. RNA polymerases achieve typical transcription speeds of
20-40 nucleotides per second [25].
Translation Possible products of transcription are different types of RNA, the most
prominent of which are messenger RNA (mRNA) that encodes a protein, ribosomal RNA
(rRNA) which is a part of the ribosomes and transfer RNA (tRNA) which acts as carrier for
single amino acids. Translation is a much more complex process than transcription since a
sequence of four different nucleotides now has to be used to assemble a sequence of up to 22
different amino acids of which the protein is composed of. In this connection is the genetic
code divided into groups of three nucleotides, the codons, which encode an amino acid
each (some amino acids are encoded by more than one codon). Some codons (UAA, UAG,
UGA) do not encode an amino acid but are the stop signal of the translation process.
The translation process is catalyzed by ribosomes, complex cellular machines composed
of proteins and rRNAs. Translation works as follows: ribosomes consist of two separate
subunits which unite on the mRNA. The now functional ribosome provides a binding site at
which tRNAs recognize their specific codon on the mRNA and bind to it. This brings the
amino acids that the tRNAs carry on their back into close contact. Subsequently a peptide
bond is created between the carboxy-terminus of the already synthesized polypeptide chain
and the amino group of the newly arrived amino acid. In this manner the polypeptide chain
grows out of the ribosome until the stop codon on the mRNA is reached and the translation
process terminates.
Although the ribosomes in prokaryotes and eukaryotes have the same function, the
structure and composition of them is different. Phrased in Svedberg, the unit of sedimenta-
superstructures, the chromosomes.
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tion in a centrifuge, prokaryotes and eukaryotes have 70S and 80S ribosomes respectively.
Eukaryotic ribosomes translate about two amino acids per second, prokaryotic ribosomes
even about 20 amino acids per second [25].
Protein folding The product of the translation step is a polypeptide chain which is not
yet a functional protein. Firstly, this chain has to fold into the correct three-dimensional
configuration of the target protein. Due to its length and flexibility one can expect the
polypeptide chain to be able to fold into a great number of configurations. This number
however is severely limited by noncovalent bonds (hydrogen bonds, ionic bonds and van
der Waals attractions) between different parts of the chain. The conformation that is
ultimately adopted is the one with the maximum strength of these interactions as well as
with optimal shielding of nonpolar amino acid side chains from the hydrous environment
(hydrophobic effect) and therefore minimal free energy.2
Although the conformation of each protein species is unique there are two smaller scale
patterns that can be found frequently – the so called α helix and β sheet (Fig. 2.2). Their
ubiquity stems from the character of their emergence which is hydrogen bonds between
N–H and C=O groups of the polypeptide backbone that do not involve particular amino
acid side chains.3
The crowded interior of living cells makes proper folding of proteins difficult therefore
special helper proteins called “molecular chaperons” assist the amino acid sequence in
adopting the correct conformation [25].
Posttranslational modification Some classes of proteins require additional modifica-
tions apart from correct folding in order to become fully functional [25, 29]. There are many
different types of modifications. Some examples are oxidation, cofactor binding, disulfide
bond formation, glycosylphosphatidylinositol (GPI) anchor formation, or addition of a
polysaccharide group (glycosylation).
With respect to synthesizing a specific protein in a host that does not naturally ex-
press that protein (e. g. through plasmid DNA transfection) or in a cell-free system as
described later on one has to make sure that either the target protein does not require any
2The postulate that a protein’s native structure is defined by its amino acid sequence is known as
“thermodynamic hypothesis” or “Anfinsen’s dogma” after Nobel Laureate Christian Anfinsen [26, 27].
3In this context biologists defined four levels of organization of the protein structure: the amino acid
sequence is called “primary structure”, α helices and β sheets comprise the “secondary structure”, the
whole three-dimensional conformation is the “tertiary structure” and a complex comprised of more than
one protein is termed “quarternary structure”.
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Figure 2.2: As an example for the crystal structure of a protein the ribbon diagram of
SRP9/14 is shown. α helices are depicted in blue and β sheets are depicted in red (taken
from [28]). The ribbon diagram representation has been established as a powerful tool for
the visualization of the often times complex 3D configuration of proteins.
modifications specific to its natural host or provide such modifications artificially.
2.1.2 History of cell-free systems
Pioneering work on the mechanism of gene expression that would eventually lead to com-
mercially available easy to use cell-free protein synthesis systems started in the 1950s when
it was found that encapsulation in a cell is not necessary for the gene expression reaction
[30]. Littlefield et al. showed RNA translation in a cell-free system of rat liver in 1955 [31]
and other groups subsequently demonstrated protein synthesis in E. coli extracts [32–34].4
However, protein that was synthesized in these early papers stemmed from native mRNA
which was still included in the cell-free extract. Nirenberg and Matthaei were the first to
achieve translation of an exogenous RNA in an E. coli cell-free system in 1961 [36]. This
was further improved by removing endogenous DNA and RNA from the cell-free extract
by nuclease treatment and by using the more stable DNA instead of RNA as the carrier of
the genetic information [37, 38]. Besides E. coli extract cell-free systems based on rabbit
reticulocyte lysate and wheat germ extract were also developed [39, 40]. These three sys-
tems are the basis for most commercially available in vitro protein synthesis kits nowadays.
These kits do not contain endogenous polymerases but are loaded with highly promoter
4With these early publications one has to bear in mind that many cellular functions were still unknown.
For example, only in 1959 had it been firmly established that ribosomes are a fundamental part of protein
synthesis [35].
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specific and fast working polymerases like the one of the T7 phage. This also means that
a standardized promoter sequence on the DNA template can be used, in this case the T7
promoter.
Protein synthesis systems made up from cell extracts may exhibit several disadvantages
like short reaction lifetime due to heavy waste of energy resources and sub optimum protein
yield due to the presence of leftover nucleases and proteases. It was reasoned that a system
reconstituted solely from purified components could circumvent these problems. Indeed,
in 2001 Shimizu et al. presented such a system which they termed the PURE system
(”Protein synthesis using recombinant elements”) [20, 21]. A reconstituted system has
the additional advantage that the target protein does not require a polyhistidine-tag for
purification. Instead all the system’s components are prepared with such a protein tag
and the target protein can easily be purified by ultrafiltration and subsequent affinity
chromatography [20].
2.1.3 Components of cell-free systems
A minimal cell-free system consists of about 100 individual components which can be
broadly classified into four categories (see Tab. 2.1). Nucleoside triphosphates (NTPs)
provide the necessary energy for the protein synthesis reaction and are also used as raw
material for mRNA production. Translation requires the aid of initiation, elongation and
release factors (IF, EF, RF) as well as ribosome recycling factor (RRF). Aminoacylation
is the process of covalently binding an amino acid to the appropriate tRNA. An efficient
energy regeneration system prevents premature cessation of protein synthesis (see also sec.
2.1.4).
The much lower complexity of transcription (solely NTPs and RNA polymerase) com-
pared to the translation system explains why it is beneficial to add the additional transcrip-
tion step to a cell-free system and use stable DNA instead of much more easily degradable
mRNA as template.
Cell-free systems differ from cells not only in their reduced complexity of composition
but the components are also much more diluted. Polymerase and ribosome concentrations
are about one order of magnitude lower and the overall protein concentration is about two
orders of magnitude lower (the interior of a cell must not be thought of as a fluid with
widely distributed solid bodies but a tightly packed conglomeration of solid bodies with
almost no space in between, see Fig. 2.3).
Many proteins require the help of chaperons or specific post-translational modifications
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Cell-free system E. coli
Transcription system:
DNA (3nM) 5nM
RNA Polymerases (100nM) 500− 800nM
NTP mix (1− 2mM) 1.3− 7.0mM
Translation system:
Ribosomes (2.4µM) 30µM
20 amino acids (300µM) 1.5mM
Transl. factors IF, EF, RF, RRF
tRNA mix
Aminoacylation comp.
Energy sources:
NTP mix (1− 2mM) 1.3− 7.0mM
Regeneration system
Other components:
Buffer
(Chaperons)
(Glycosylation comp.)
(Phosphorylation comp.)
Table 2.1: Components of a minimal cell-free system; concentrations of some key elements
in a cell-free system and in E. coli are give for comparison [21, 47].
like glycosylation or phosphorylation which are not provided by cell-free systems [41]. It
has been found that the addition of chaperons helps in vitro synthesized proteins to fold
correctly in some cases but fails in others [42–44]. Different strategies are being pursued
with respect to cell-free glycosylation or phosphorylation, for example a cell-free system
based on insect cell extract has been shown to provide core protein glycosylation enzymes
[45]. Another suggested approach is to use non-natural amino acids that carry the desired
modification [46] (for a review on this matter see [41]).
2.1.4 Energy supply in cell-free systems
Energy in the form of ATP is used up by the aminoacylation reaction and in the form
of GTP energy is required to fuel the ribosomes [30]. However, it is not sufficient to
simply provide an ample supply of these energy resources in a cell-free system. NTPs are
quickly hydrolyzed by NTPases present in the system as well as by non beneficial reactions
competing with gene expression [30, 49]. For the protein synthesis reaction to run over
an extended period of time it is necessary to somehow maintain proper NTP levels. Two
different approaches to this challenge have been developed: continuous-flow/continuous-
exchange cell-free systems and the incorporation of an energy regeneration motif.
In continuous-flow systems the reaction reservoir containing the transcription/trans-
14 2. Basic concepts
Figure 2.3: The interior of cells is very crowded with almost no free space in between
individual components. Here a snapshot of a simulation of protein diffusion inside a cell is
shown. Due to the crowded environment diffusion coefficients can be ten times lower than
in solution (anomalous diffusion) (reprinted by permission from Macmillan Publishers Ltd:
Nature News [48], copyright (2009)).
lation machinery (DNA template, polymerases, ribosomes etc.) is continuously fed with
resources (NTPS, amino acids etc.). Conversely reaction products (inorganic phosphate,
NMPs, synthesized protein) are continuously removed through an ultrafiltration membrane
which holds back the components of the reaction machinery due to their higher molecular
weight. This way in vitro protein synthesis can easily go on for 40h instead of only two to
three hours like it does in batch format [50]. Continuous-exchange formats use a similar
but somewhat simpler approach where the feeding solution is not pumped actively but
diffuses into the reaction volume through a dialysis membrane [41] (see Fig. 2.4 A). Both
approaches suffer from two drawbacks: the setup is more complex than a simple batch
format cell-free system and they cannot readily be used in micro-volume, high-throughput
format, an important field of application for cell-free protein synthesis systems.
An “energy regeneration system” means that ADP and GDP that accumulate in the
protein synthesis reaction are converted back to ATP and GTP. There are a number of
possibilities to achieve this which differ in the efficiency of conversion and in the cost of the
required components – an important factor in the success of individual commercial protein
synthesis systems. For example, phosphoenol pyruvate and pyruvate kinase or creatine
phosphate and creatine kinase can be included in a cell-free system to set up an energy
regeneration motif, see Fig. 2.4 B and [51, 52].
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Figure 2.4: A) Different modes of operation have been developed for cell-free systems. The
batch format is the easiest to set up and operate. However, depletion of resources and/or
accumulation of waste will lead to the cessation of protein synthesis after about 3h. The
continuous flow format was developed in order to counter this problem. Buffer containing
the necessary resources is continuously fed into the reaction volume while protein product
and reaction waste is pumped down through an ultrafiltration membrane. The complexity
of this setup however makes it impractical for regular laboratory use. Therefore a third
format was developed. In continuous exchange cell-free systems the feeding buffer and the
reaction volume are separated by a dialysis membrane. Reaction resources as well as by-
products can diffuse through this membrane [41]. B) A typical energy regeneration scheme
incorporated in cell-free systems. Creatine phosphate (CrP) and ADP are converted to
creatine and ATP by creatine kinase (CK). Conversely ATP is used by nucleoside diphos-
phate kinase (NDK) to convert GDP to GTP. GTP in turn is used up in the translation
reaction. In this scheme inorganic phosphate (Pi) accumulates as a byproduct and can
eventually contribute to the cessation of cell-free protein synthesis [52].
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2.2 Exogenous gene expression in living cells
The expression of endogenous genes in a cell is under the control of a sophisticated regu-
lation network where a specific signal is needed to activate genes. One example of such an
activation mechanism are certain signaling molecules that bind to the DNA and cause a
conformational change which makes the promoter of the gene accessible. Another example
are signaling molecules that bind to a repressor that blocks a promoter. This causes the
repressor to detach from the DNA and activates the gene [25]. A cell usually carries only
one or two copies of a gene, thus when a gene is being transcribed only some tens of mRNAs
are produced before the gene is switched off again. These short intervals of mRNA tran-
scription are termed ”bursts”. Regulatory proteins are only present in an order of several
hundred [53]. These small copy numbers cause endogenous gene expression in cells to be
noisy (that is showing strong fluctuations over time [54, 55]). From this also follows that
most of the noise arises from transcription whereas translation contributes only weakly due
to the higher number of molecules involved.
Cells do not only express endogenous genes but they can also be made to express
exogenous ones. Viruses have developed strategies to overcome the barrier that the cellular
membrane poses and to insert their genetic code into the cell. This code is then processed
by the cellular gene expression machinery but with the difference that the virus DNA has
no off-switch and the expression does not happen in bursts but in one continued rise until
eventual cell death.
The stage of development of artificial gene ferries is nowadays sufficiently high to use
them as reliant vectors for gene delivery to eukaryotic cells. A widespread class of these ar-
tificial gene vectors are cationic lipids or polymers that encapsulate the DNA. The delivery
process of such vectors to an eukaryotic cell consists of cellular uptake via the endosomal
pathway, escape from the endosome, transport to and entry of the nucleus and finally un-
packing of the enclosed DNA (compare Fig. 5.1 in chapter 5). If such exogenous genes
do not need a signaling molecule to be activated, their gene expression profile does not
show the typical burst behavior of endogenous genes but a continuous rise of the target
protein level until a steady state between protein production and degradation via proteases
is reached [56].
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2.3 Modeling gene expression with rate equations
There are various approaches to modeling gene expression behavior which differ in the level
of detail they feature [57]. Binary models only confer “on” and “off” states to individual
genes. The computational cost of such models is comparably low but due to the strong
simplification such models fail to reproduce the more detailed features of gene expression.
One step more complex are deterministic rate equation models. In these models the
dynamics of the concentration of key components like mRNAs or proteins are examined.
Each component is assumed to be synthesized and degraded with a certain rate. Mathe-
matically this can be described using systems of ordinary differential equations (ODEs) of
the form
d
dt
B = σA− δB (2.1)
where A and B are concentrations of mRNAs or proteins and B is the product of A; σ is
the synthesis rate of B and δ its degradation rate. Such models can be solved analytically
if they are not too complex and otherwise numerically using well established computational
tools. Although these models are per se deterministic they can also be adopted to reflect
stochastic effects by introducing noise terms that account for varying levels of components
of the gene expression apparatus.
The highest level of detail is conveyed by the class of stochastic kinetics models. This
approach accounts for stochastic synthesis and decay of individual components. It is well
suited to analyze reaction fluctuations due to small copy numbers of participants. However,
the drawback is a high computational cost and this class of models does not yield an
analytical solution which could further the understanding of the system [55, 57].
Cell-free gene expression comprises of large systems, that is intrinsic stochasticity does
not play a dominant role. In fact the protein yield is predetermined by DNA template
amount or experimental timing (compare experimental results in chapter 4). In this study
it was desired to derive a model that is readily comprehensible and easily adaptable to
individual cell-free systems. In addition the model was to have comparably low computa-
tional cost in order to quickly run it multiple times to test modifications. For these reasons
the ODE based approach was chosen.
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2.4 Green fluorescent protein – GFP
2.4.1 History of GFP
In 1955 D. Davenport and J. Nicol published their studies on bioluminescence of hydrome-
dusae [58]. One species they studied was the jellyfish Aequorea victoria. It took another
seven years before in 1962 Osamu Shimomura and coworkers reported the extraction and
purification of a protein from A. victoria which fluoresced when induced with Ca++ [59].
This protein which they termed “Aequorin” fluoresced in a bluish light (λmax = 470nm)
when purified whereas A. victoria itself showed greenish fluorescence (λmax = 509nm, see
Fig. 2.5 A). Shimomura et al. speculated that this discrepancy might be due to an energy
transfer from Aequorin to another fluorescent protein present in A. victoria, namely GFP
which they had also been able to purify. This assumption was verified in the early 1970s
[60, 61]. GFP differed from Aequorin and any other fluorescent protein known to that date
in the fact that it does not require continuous uptake of chemical energy like Ca++, solely
excitation by UV or blue light. This would later prove to be one of the major factors in
the usefulness of GFP in bioanalytical research as target cells do not have to be injected
with potentially disturbing chemicals.
The structure of the GFP chromophore was first described by O. Shimomura in 1979
[62] and later in 1993 Cody et al. proposed some slight changes in the model [63]. The
crystal structure of wild type GFP was first described by Yang et al. [64] in 1996.
However, it can be said that the true start of the success story of GFP was in the early
1990s. Prasher et al. cloned its cDNA and first described its nucleotid sequence in 1992
[65]. Based on this success, Chalfie et al. in 1994 showed that it is possible to transfer the
GFP gene into new host organisms like E. coli or the roundworm C. elegans and have them
produce the functional i.e. fluorescent protein [66]. Another important step in the growing
usefulness of GFP was the generation of mutants with improved fluorescence properties
and different wavelengths like blue, cyan and yellow (Fig. 2.5 B) which was first reported
by the group of R. Tsien [67]. Nowadays GFP and its derivatives are widely used as marker
genes in a wide variety of bioanalytical applications. For their contributions to this field
Osamu Shimomura, Martin Chalfie and Roger Tsien were awarded the 2008 Nobel Prize
in Chemistry [68].
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Figure 2.5: A) GFP was first isolated from the jellyfish A. victoria. The bluish green
color of A. victoria as it is shown here stems from GFP that receives its excitation energy
from another fluorescent protein termed Aequorin via Fo¨rster resonance energy transfer
(FRET). Aequorin fluorescence in turn can be induced by Ca++. This mechanism explains
why the jellyfish does not need an excitation light source in order to exhibit GFP fluores-
cence (reprinted by permission from John Wiley & Sons, Inc.: Journal of Microscopy [69],
copyright (2005)). B) Mutants of GFP were created that not only exhibit improved fluores-
cence properties but also have their excitation/emission maximum at different wavelength
than wild type GFP. This library of mutants now spans the complete visible spectrum
from blue to red light (taken from [70]).
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Figure 2.6: GFP is an eleven stranded beta-barrel protein. The top and bottom of the
barrel are sealed by short α-helices. The chromophore is located in the center of the barrel
were it is protected from environmental influences (taken from [73]).
2.4.2 Fluorescence mechanism
GFP has a β-barrel structure consisting of 11 strands with short α-helices which seal the top
and bottom of the barrel and also hold the chromophore in place in the middle of the barrel.
Thus in correctly folded GFP the chromophore is completely protected from environmental
influences like quenching by outside oxygen (Fig. 2.6) [64]. The chromophore is composed
of the amino acid sequence serine-tyrosine-glycine on positions 65-67. The formation of the
chromophore in a freshly translated protein works as follows: through dehydration Gly-67
cyclizes with the carbonyl group of Ser-65 to form imidazolin-5-one. Then, in the presence
of molecular oxygen dehydrogenation occurs and creates a conjugated pi-electron resonance
system comprising of the imidazolin ring and the tyrosine phenyl ring (Fig. 2.7) [71, 72].5
As one can see the formation of the GFP fluorophore (the so called GFP maturation) does
not depend on any A. victoria specific enzymes but it is fully autocatalytic. This property
makes the application of GFP as such a versatile reporter gene possible in the first place.
2.5 Heavy water
In 1931 Harold Urey substantiated the isotope deuterium (for this discovery he was awarded
the 1934 Nobel Prize in Chemistry) [74]. Two years later Gilbert Lewis reported about
the purification of deuterium oxide (also called heavy water), that is a water sample with
5An interactive Java tutorial depicting the formation of the GFP fluorophore can be found at [72].
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Figure 2.7: GFP maturation as described in Ref. [71, 72]: the first step is a torsional rear-
rangement of the amino acid sequence which brings the carbonyl group of Ser-65 into close
proximity of the amino group of Gly-67 (here the result of this rearrangement is shown).
Subsequently the system dehydrates and an imidazolin-5-one ring forms (cyclation). Then
in the presence of molecular oxygen the α − β carbon bond of Tyr-66 oxidates and thus
the conjugated pi-electron system is expanded to include Tyr-66. The protonated form of
GFP is responsible for the GFP excitation peak at 395nm whereas the deprotonated form
is excited at 470nm (eGFP at 488nm).
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deuterium (2H) instead of protium (1H) atoms [75].6 Deuterium oxide can also be found in
nature: a small percentage of natural water molecules (about 0.01%) contains deuterium
instead of protium. Heavy water features slight differences in its physical properties com-
pared to normal water: it is about 11% denser, its viscosity is about 23% higher, the energy
required for dissociation is higher etc. An overview over the physical properties of H2O
and D2O is given in table 2.2.
Heavy water can be produced for example by electrolysis utilizing the kinetic isotope
effect: since deuterium is twice as heavy as protium the vibrational zero-point energy of
its bonds is much lower and the activation energy of reactions that break these bonds is
accordingly higher [76]. Electrolysis therefore breaks light water into hydrogen and oxygen
but leaves deuterium oxide largely intact. Commercially available heavy water can have
purities as high as 99.9%.
The fields of application of deuterium oxide are quite diverse. For example it is used
in nuclear power plants of the heavy water reactor type. Heavy water absorbs neutrons
to a lesser extent than light water therefore it is possible to use non-enriched uranium
in these reactors. Deuterium oxide is further used in nuclear magnetic resonance (NMR)
spectroscopy because it has a distinct magnetic moment and can be clearly separated from
the background water signal. Especially NMR studies of proteins with more than 20 kDa
stringently require 80−90% deuteration [77]. Another field of application was the Sudbury
Neutrino Observatory (in operation 1999-2006) which was filled with 1000 t of heavy water.
In neutrino detectors using light water only electron scattering of neutrinos is detectable.
In heavy water neutrinos can also interact with the deuterium nucleus, fissioning it. This
weak force interaction can happen via a Z boson (for electron neutrinos) or via a W boson
(for all neutrino flavors). In this manner was it possible to experimentally verify neutrino
oscillations and solve the solar neutrino problem [78].
Moreover heavy water affects cellular proliferation if it has sufficiently accumulated in
the organism. It is assumed that the main target of the inhibitory effect of heavy water
is the mitotic spindle formation process. Eukaryotic cells are unable to divide without
the mitotic spindle. A more detailed description of the effects of heavy water on living
organisms can be found in section 6.1.
6To be precise the term heavy water could also be applied to water containing the oxygen isotopes 17O
and 18O.
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Hydrogen oxide Deuterium oxide
Molar mass (g/mol) 18.015 20.029
Max. Density (g/cm3) 0.999975 1.10589
pH and pD resp. (at 25◦C) 7.00 7.43
Viscosity (at 20◦C, mPa s) 1.0016 1.2467
Freezing point (◦C) 0.00 3.82
Boiling point (◦C) 100.00 101.4
Melting heat (J/mol) 6.01 6.34
Evaporation heat (J/mol) 44.01 45.47
Table 2.2: Comparison of the physical properties of H2O and D2O.
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Chapter 3
Materials and Methods
3.1 Fluorescence microscopy
The spontaneous emission of light when an excited electron state goes into a state of
lower energy is called luminescence. This phenomenon is subdivided into fluorescence
which comprises spin allowed transitions (that is ∆S = 0) between energy states and
phosphorescence which comprises spin forbidden transitions (∆S 6= 0). Typical life times
of excited states are up to a few micro seconds for fluorescence and from milliseconds
to hours for phosphorescence (Fig. 3.1 A). The emitted photon of a fluorophore usually
has lower energy than the one absorbed because the fluorophore relaxes to the lowest
vibrational level of the excited state before it relaxes to its electronic ground state via
photon emission. This effect is called Stokes-shift after the Irish physicist George G.
Stokes. Fluorescence microscopy makes use of this shift as it makes it possible to separate
excitation and emission light in one optical path through the use of suitable filters (Fig.
3.1 B). Non-cytotoxic fluorophores like GFP and its derivatives can be bound to virtually
any component of a cell in order to monitor it in vivo. Because fluorophores emit their
own light the resolution of fluorescence microscopes is not limited by Abbe’s law1.
High excitation intensities or sufficient excitation/emission cycles lead to the photo-
chemical destruction of fluorophores. This process is called photobleaching. Until recently
mercury-vapor lamps were the prevalent light source for fluorescence microscopes. These
lamps emit light in the whole visible spectrum as well as at UV wavelengths. A filter
is used to extract the desired excitation wavelength. However, such filters are not 100%
1According to Abbe’s law the minimum distance of to points that can still be identified as distinct is
d = λ2n sinα where λ is the wavelength, n the refractive index and α half the angular aperture.
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Figure 3.1: A) The possible transitions of electrons between different energy states in
a fluorophore (Jablonski diagram). Relaxation by emission of a photon competes with
radiation-free processes. In a proper fluorophore photon emission is the dominant pro-
cess. Transitions that involve spin conversions have significantly longer lifetimes than spin
allowed transitions. B) Schematic setup of a fluorescence microscope. Excitation and emis-
sion light are centered around different wavelengths due to the Stokes shift. Thus their
beam paths can be separated using a dichroic mirror.
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Figure 3.2: A) Technically FCS is usually realized on a confocal fluorescence microscope.
Confocal microscopes are equipped with a pinhole in front of the detector which only light
from the confocal plane can pass as well as from slightly above and below due to the
diffraction limit. This yields a confocal volume as depicted by the red oval. The detector
has to feature fast single photon sensitivity therefore photon multiplier tubes or avalanche
photo diodes are used. B) Fluorescent molecules diffuse in and out of the confocal volume
which leads to fluctuations in the recorded fluorescence intensity. C) Autocorrelation data
of the data in B) and best fit according to equation 3.3.
impermeable for the wavelengths they should block and a small percentage is transmitted.
This way photobleaching is stronger than it would be with ideal filters, especially because
of the high energy UV light transmitted. Over the last years high performance LEDs have
been developed and are now a preferred light source for fluorescence microscopy despite the
disadvantage that a different LED is needed for each excitation wavelength. In addition
to avoiding the harmful UV light the illumination profile of LEDs is preadjusted and is in
general much more uniform than that of mercury-vapor lamps.
3.2 Fluorescence Correlation Spectroscopy – FCS
FCS is a fluorescence fluctuation analysis method with single molecule sensitivity. It was
developed in the 1970s by Douglas Magde, Elliot Elson and W. W. Webb [79–81]. Fluores-
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cent particles diffuse in and out of an excitation volume which leads to temporal fluctuations
in the recorded fluorescence intensity (Fig. 3.2). In FCS the agreement between the signal
at time point t and after a time lag t+ τ is analyzed via temporal autocorrelation:
G(τ) =
〈δF (t)δF (t+ τ)〉
〈F (t)〉2 (3.1)
Here the pointed brackets denote averaging over time and δF (t) = F (t) − 〈F (t)〉 is the
deviation from the mean fluorescence signal. FCS is technically realized with a confocal
microscope setup2. Thus the excitation volume is usually of the order of one femtoliter and
typical sample concentrations are in the nanomolar regime. Assuming proper adjustment
of the optical pathway the excitation volume can be well approximated by a 3D Gaussian:
I(x, y, z) = I0 exp
(
−2(x
2 + y2)
ω2xy
− 2z
2
ω2z
)
(3.2)
where I0 denotes the peak intensity and ωxy, ωz are the Gaussian’s radii in the respective
directions. With this a model for the observed intensity fluctuations can be created. In the
simple case that the fluorescent particles are driven by Brownian motion and can diffuse
unrestricted in three dimensions the analytical solution is [82]:
G(τ) =
1
N
· 1
1 + τ
τD
· 1√
1 + τ
S2τD
(3.3)
Here N is the mean number of particles in the excitation volume, S = ωz/ωxy is called
structure parameter and τD is the average diffusion time through the focal volume in the
xy-plane. τD is related to the diffusion coefficient of the particle D via
τD =
ω2xy
4D
(3.4)
Employing the Stokes-Einstein relation FCS also returns the hydrodynamic radius R of
the diffusing particles:
D =
kBT
6piηR
(3.5)
2A confocal setup is basically a fluorescence microscope with a pinhole in front of the detector. Only
emission light from the focal plane can pass this pinhole which means that the sample can be dissected
along the optical axis and a 3D image can be created. The detector is usually a photomultiplier or an
avalanche photo diode for very high sensitivity.
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where kB is the Boltzmann constant, T the temperature of the sample and η the viscosity
of the medium.
Thus FCS is a highly sensitive analysis method for quantitative studies of diffusion
coefficients, concentrations, chemical reaction kinetics or hydrodynamic radii. Great ad-
vantages of FCS are single cell sensitivity and the ability to observe fluorescently tagged
particles in situ in living cells.
3.3 Considerations for quantitative measurements
An important requirement of this thesis was to measure fluorescence quantitatively – even
for very low concentrations of fluorophores. Therefore considerable effort was put into iden-
tifying and eliminating sources of errors. For example in the spectrometer it was found
that it is necessary to fix the cuvette with a chock in the sample holder otherwise small
misalignments produce considerably different results in repeated measurements. Further-
more, different batches of cell-free kit were found to produce divergent GFP levels. This
may be due to intrinsic variations in composition of the batches or due to unequal handling
in the laboratory (like small inaccuracies in aliquoting the cell-free kit or different storage
times). Associated experiments should therefore be conducted using one batch of cell-free
kit if possible. In addition is it advisable to create a stock of cell-free kit components for
parallelized measurements instead of pipetting components for each replica individually in
order to minimize the effect of pipetting inaccuracy.
Experimental timing is a further aspect that needs to be heeded. First, crucial com-
ponents of the cell-free system begin to degrade after thawing and measurement results
diverge if the timing is not consistent. Second, at sample volumes of only some micro liters
evaporation is a problem and samples need to be quickly sealed during preparation in or-
der to avoid noticeable volume loss and therewith change of component concentrations. In
this context one needs to keep in mind that polydimethylsiloxane (PDMS) which is often
used to create structures for microfluidics is not completely air tight. Therefore micro liter
volume cell-free expression in PDMS casts is prone to evaporation during measurements,
especially when the experiment is not conducted at room temperature but at 37◦C.
It was also found that adjusting the sample temperature to exactly 37◦C is not trivial
on the fluorescence microscope and FCS setups. Good accuracy is necessary because the
protein synthesis reaction is temperature sensitive. On the spectrometer and on the plate
reader respectively the sample is put in a enclosed temperature controlled box where the
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temperature control works well. On microscopes the equivalent to this ideal would be to
enclose the whole microscope setup in a thermo box. When only the sample is heated
like with the ibidi Heating System (ibidi, Germany) one has to keep heat loss in mind.
This means that samples should not be put solely on thin bottoms like cover glass slips
but instead on, for example, six well plates or petri dishes which such heating systems are
made for and which are thicker and show less heat loss. Attention should be paid to the fact
that in such heating chambers the actual temperature can diverge from the predefined one
depending on room temperature, air conditioning or chamber type. A digital thermometer
should be used to check the proper setting. Immersion objectives should be avoided where
possible as it was found that objective heaters may not be sufficient to counteract heat
loss through an immersion objective that is in direct contact with the sample.
The need for good quantitative accuracy also sets a limit as to how far samples could be
downsized. Downsizing is beneficial first because commercial cell-free kits are expensive and
second because it allows for massive parallelization of measurements in micro well format.
However it was found that at sample volumes below about ten micro liters measured
fluorescence levels varied considerably between individual measurements. Note that these
fluctuations can not be explained by low copy numbers of cell-free system components: the
minimum sample volume tested was 0.2nl. This volume contains about
• 1− 104 DNA molecules (depending on the concentration)
• 103 RNA-polymerases
• 104 ribosomes
• 106 amino acids
Unequal filling due to pipetting inaccuracy, surface effects due to imperfect passivation of
surfaces (cell-free kit components carry his-tags and may bind to surfaces) as well as evap-
oration of samples during measurements may all contribute to the observed discrepancies.
It is further necessary to take the comparable instability of mRNA into account.
RNAses are ubiquitous and very sturdy3 therefore certain precautions like using RNAse-
free pipette tips, cleaning the working space with RNAse removal agent and treating sample
holders in a plasma oven are inevitable in order to avoid sample contamination.
3In fact RNAse A can be isolated by boiling cellular extract until all other enzymes are denaturated.
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Figure 3.3: A) Micro channels for calibration. In the photograph on the left the channels
are filled with red food coloring for better visibility. The center shows a fluorescence image
of the five channels filled with GFP calibration standard (from the top channels two and
three and four and five respectively contain the same GFP concentration). On the right
a histogram following a vertical line through the five channels is shown. B) Calibration
curve for translating arbitrary fluorescence units into numbers of GFP molecules. Similar
calibration curves were established for spectrometer and plate reader.
3.4 Calibration standard for GFP
GFP synthesis was measured fluorescently on a number of instruments (spectrometer,
plate reader, fluorescence microscope) depending on the requirements of the respective
measurement. These instruments yield arbitrary fluorescence units as readout. In order
to translate this readout into a meaningful quantity (that is number of GFP molecules or
GFP concentration) it is therefore necessary to establish a calibration curve. This can be
done by measuring the fluorescence of a GFP standard with known concentration.
GFP standard was expressed in plasmid transformed E. coli. The plasmid contained ex-
actly the same GFP sequence as the one used for experiments thus ensuring complete anal-
ogy of the resultant GFP. A his-tag was attached to the end of the GFP sequence in order
to purify it using high performance liquid bioaffinity chromatography. GFP stock in phos-
phate buffered saline (PBS) pH 7.4 contained the following additives: Tween 20 (0.001%)
to prevent binding to surfaces and sodium azide 0.002% as a preservative. The GFP
concentration of the stock solution was measured photometrically4 on a Nanodrop 1000
spectrophotometer (Thermo Scientific, Germany) with GFP (488nm) = 55000M
−1cm−1.
The concentration was also measured by fluorescence correlation spectroscopy for verifica-
tion.
4Absorbance and concentration of a solution are connected by the Lambert-Beer law: A =  · c · d with
(λ) the molar extinction coefficient of the solvent at the respective wavelength and d the optical path
length.
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Figure 3.4: Working principle of molecular beacons: In the absence of the target sequence
the beacons fold back on themselves. In that case the ends are in close contact and the
fluorophore is efficiently quenched. However, binding to the target is energetically favorable
and therefore in its presence the beacons open up and fluorescence can be detected.
Calibration curves for spectrometer, plate reader and fluorescence microscope were
established using the same instrument settings and sample volumes as in the measurements.
For calibration of the microscope GFP calibration solution was filled into micro channels
cast in PDMS, see Fig. 3.3A. PDMS casts were produced using a silicon master created
with standard photolitography methods. PDMS chips were glued to glass cover slips via
oxygen-plasma hydrophilisation. The channels were passivated by treating them with PBS
containing 3µM Pluronic F108 for 20h at 4◦C. They were subsequently washed with
PBS three times and dried under a nitrogen flow. Knowledge of the channel height (width
20µm, height 8µm, length 10mm) allows for calculation of GFP molecules in a defined
region of interest.
3.5 Molecular beacons for mRNA labeling
If mRNA levels are to be measured fluorescently it is necessary to apply a fluorescent label.
As described in section 4.2 labeling with unspecific RNA dye was not successful because
of a strong background signal (likely due to the dye binding to tRNA). Therefore a dye
was needed which specifically binds to mRNA and which is also not toxic for the cell-free
transcription apparatus. Molecular beacons fulfill these requirements [83]. These beacons
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Figure 3.5: Minimum free energy structure of the cell-free transcribed mRNA at 37◦C
(calculated with the NUPACK software).
are oligonucleotides with a stem-loop structure (see Fig. 3.4). The stem forms because
two complementary sequences at the ends of the beacons anneal at temperatures lower
than their melting temperature. The loop sequence is complementary to a part of the
target mRNA and hybridizes with it when it comes into close proximity. Since the loop
sequence is longer than the stem the hybrid is more stable than the hairpin structure and
it is therefore the prevalent configuration. This separates the two ends of the beacon and
therewith the fluorescent donor-quencher pair attached to said ends5. From this point on
fluorescence of the donor can be detected.
The minimum free energy structure of the cell-free transcribed mRNA at 37◦C was
modeled using the software package NUPACK (www.nupack.org), see Fig. 3.5. A readily
accessible stem-loop sequence was chosen as binding site for the beacons. Molecular bea-
cons with the sequence 5′−TCGCCGTGGGGGTGTTCTGCTGGTGTGGTCGGCG−3′
were ordered from biomers.net (Germany). Beacons carried the fluorescent dye Cy5 on the
5′ end and the dark quencher BBQ-650 on the 3′ end. Since each mRNA is labeled with
exactly one Cy5 molecule there is a one to one relation between the Cy5 and mRNA concen-
5Fluorophores in very close proximity (less than 10nm) whose respective emission/excitation spectra
overlap exhibit non-radiative energy transfer from the “donor” to the “acceptor” due to dipole-dipole
interactions [84]. This mechanism is termed “Fo¨rster Resonance Energy Transfer” (FRET) after the
German physicist Theodor Fo¨rster. FRET is a highly sensitive technique for measuring changes in length
as the transfer efficiency E scales with the inverse of the sixth power of the distance: E = 11+(r/R0)6 . R0
is the so called Fo¨rster radius, it depends on the specific donor/acceptor pair.
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Figure 3.6: Principle of cell-free protein synthesis in a combined transcription/translation
system.
tration in the sample. A Cy5 calibration curve using a Cy5 dilution series was established
similar to the one for GFP described above. Molecular beacons were added to samples in
about tenfold the expected mRNA concentration to ensure saturation of binding partners.
RNA mimics of GFP It should be noted that recently (after RNA measurements
reported here were done) a new promising variant of RNA labels was reported [85]. In GFP
the fluorophore sequence (Ser65 − Tyr66 −Gly67) is located in the center of the molecule,
shielded from outside influences (compare Sec. 2.4.2). Paige et al. describe a GFP analog
based on a RNA aptamer that binds a fluorophore in a similar way. They used derivatives
of the GFP fluorophore for their work because these do not show cytotoxicity and fluoresces
only when bound to the protective aptamer (free GFP fluorophores dissipate their energy
non-radiatively). The authors managed to produce a palette of RNA-fluorophore complexes
which cover the visible spectrum from 300nm to 500nm. They demonstrated that these
aptamers are transcribed in living cells and can be used to depict RNA dynamics within
them after a brief incubation with the fluorophore. As the authors note this system might
be of great merit for RNA-RNA, RNA-protein interaction studies as well as simultaneous
observation of various RNAs.
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3.6 Cell-free protein synthesis
Plasmid DNA for cell-free GFP synthesis The gfpmut1 mutant of the GFP gene
taken from the pEGFP-N1 vector (BD Biosciences Clontech, Germany) was cloned into
the pET-23b vector (Novagen, USA). pET-23b carries a T7 promoter sequence and is
therefore suitable for cell-free gene expression. gfpmut1 exhibits higher photostability
and fluorescence compared to wild-type GFP. It also has its excitation maximum shifted
to 488nm which better matches the standard fluorescein microscope filters. pET-23b
plasmid DNA was purified in deionized water. The concentration was measured with a
NanoDrop spectrophotometer (Thermo Scientific, USA) by absorption at 280nm. Aliquots
were stored at −20◦C.
Sample preparation When preparing samples for cell-free gene expression great empha-
sis was put on working RNAse free. The working space on the laboratory bench was treated
with RNAse-ExitPlus solution (AppliChem, Germany) and solely RNAse free pipette tips
(Biozyme Diagnostik, Germany) were used. Sample holders were subjected to treatment
in a plasma oven immediately prior to measurements.
The reconstituted cell-free system PURExpress (New England Biolabs, Germany) was
used as described by the manufacturer. In short, PURExpress is provided in to solutions
“A” and “B” which can be stored in aliquots at −80◦C for at least six month. PURExpress
contains T7 RNA polymerase in about 100nM concentration and ribosomes in about
2.4µM concentration. For an experiment components “A” and “B” were mixed, DNA
was added at the desired concentration and the total sample volume was adjusted to 25µl
using RNAse free water. After filling the sample into the sample holder it was covered
with mineral oil in order to prevent evaporation. A digital temperature control unit was
used to maintain a constant 37◦C during measurements.
Data acquisition Kinetics of cell-free GFP synthesis were recorded fluorescently. Ini-
tially measurements were performed on a Fluorolog-3 spectrometer (Horiba Jobin Yvon,
Germany) due to the unparalleled sensitivity of spectrometers compared to other instru-
ments like fluorescence microscopes or microplate readers. The employed sample holder
was a fused silica ultra-micro cuvette (Hellma, Germany). Instrument parameters were as
follows: excitation wavelength 488nm, recorded emission spectrum 500 − 600nm, width
of spectrometer slits 8nm, integration time 0.1 s. Data points were recorded every 10 to
20 seconds.
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After fine tuning the measurement protocol sufficient sensitivity was also achieved with
a Fluostar Optima plate reader (Optima, Germany). Using the plate reader is advantageous
because here multiple measurements can be conducted in parallel. Here the employed
sample holder was a 96 well plate with V-bottoms (Greiner Bio-one, Germany). Instrument
parameters were: excitation/emission filter set 485/520nm, gain 2000, ten flashes per well,
bottom optics.
Data analysis Data were analyzed using the OriginPro 8.5G software. GFP emission
spectra recorded on the spectrometer were integrated and plotted vs. measurement time.
Plate reader data were background corrected by shifting time traces such that the second
data point of each curve has zero fluorescence intensity. The correction was performed
this way because the first data point of each curve showed instrument dependent erratic
behavior. Mean values were created out of associated data sets. Statistical outliers were
omitted from averaging.
3.7 Real-time PCR
Polymerase chain reaction (PCR) is an in vitro technique for the amplification of DNA
sequences [86, 87]. It was invented in 1983 by Kary Mullis who received the Nobel Prize
in Chemistry for his invention in 1993. PCR is nowadays one of the most important tools
of molecular biology. Examples for its application are screening for hereditary diseases,
determination of genetic fingerprints or functional gene analysis. The working principle of
PCR is based on the enzymatic amplification of a DNA sequence using a DNA polymerase.
The polymerase needs to be thermostable in order to endure the high temperature steps
in PCR (see below). For example the Taq polymerase originally isolated from the ther-
mophilic bacterium Thermus aquaticus fulfills this requirement. A typical PCR run goes
as follows: DNA template, polymerase, deoxynucleoside triphosphates (dNTPs) oligonu-
cleotide sequences complementary to the 3′ end of the sense and anti-sense strand of the
DNA (primer) and buffer are mixed and placed in a thermocycler. The thermocycler
executes 20-30 cycles of a temperature steps. Each cycle consists of the following steps:
• Denaturation: At about 95◦C the hydrogen bonds between the DNA double strands
are melted. This step takes about 30 seconds.
• Annealing: At 55 − 65◦C (about 5 − 10◦C below the melting point of the primers)
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primers hybridize with the complementary DNA sequence. This step takes about 30
seconds.
• Elongation: At its optimum working temperature (about 72◦C) the polymerase,
starting at the 3′ end of the primer, synthesizes a new DNA strand complementary
to the template. Taq polymerase adds about 500 bases per 30 seconds.
The newly synthesized DNA strands do not have a defined stop, they end when the poly-
merase unbinds from the template at the end of the elongation step. However, the at the
3′ end overly long strands serve as templates in the next cycle. Primers bind at their 3′
region and since the strands already have the correct 5′ end the strands synthesized now
have the correct length. As the new strands themselves serve as template in consecutive
cycles strands with the correct (short) sequence accumulate exponentially whereas overly
long strands do so only linearly (since only the original DNA serves as template for them).
Real-time PCR is a variation of the standard PCR work flow where the amount of
product is measured in each cycle. To this end a fluorescent dye like Sybr Green which flu-
oresces after binding to double stranded DNA is added to the sample and the thermocycler
needs to be equipped with a fluorescence reader.
mRNA purification and cDNA production A cell-free transcription/translation re-
action with pET 23b plasmid and PURExpress cell-free kit was conducted following the
manufacturer’s instructions. However, samples were diluted with D2O in the desired con-
centration as described in the text. After 4h of cell-free reaction at 37◦C the cell-free
transcribed mRNA was purified using the “RNA cleanup” protocol of the RNeasy Mini
Kit (Qiagen, USA). Subsequently complementary DNA (cDNA) was reverse transcribed
out of the mRNA with the SuperScript II Reverse Transcriptase kit (Invitrogen, USA).
PCR sample preparation Samples consisted of 2µl cDNA, 2µl each of forward (5’-cgc
cac cat ggt gag caa gg-3’) and reverse (5’-ggt tgt cgg gca gca gca cg-3’) primer, 10mM
dNTP mix, 2µl of 25× concentrated Sybr Green, 2U Taq DNA polymerase (New England
Biolabs, Germany) and 5µl of 10× reaction buffer.
Data acquisition Real-time PCR was carried out on a C1000 thermal cycler equipped
with the CFX96 Real-time Detection System (Bio-Rad, Germany). The PCR protocol
was as follows: initiation at 95◦C for 5min. This was followed by 30 steps of denaturation
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(94◦C, 30 s), annealing (65◦C, 30 s) and extension (72◦C, 30 s). Final extension was done
at 72◦C for 5min.
Data analysis In PCR the amount of DNA and therewith the Sybr Green fluorescence
grows exponentially with the cycle number. Therefore the sooner the observed fluorescence
crosses a manually defined threshold the higher is the amount of original template in the
respective sample. The cycle number at which each PCR curve crosses the threshold is
called the Ct value. Ct values were plotted against the D2O concentration in the respec-
tive sample and corresponding Ct values were averaged. Outliers were omitted from the
statistics.
3.8 Fabrication of lipid vesicles and supported lipid
bilayers
All lipids (Avanti Polar Lipids, USA) were stored in chloroform at −20◦C. Lipid solutions
of the desired composition were mixed under the fume hood using glass vials and syringes.
Subsequently the chloroform was evaporated under a nitrogen stream followed by over
night storage of the vials in a vacuum oven at room temperature. Lipid compositions for
giant unilamellar vesicles (GUVs) were not dried out but kept in chloroform.
Supported lipid bilayers (SLBs) were prepared as follows: SLBs consisted either of pure
1-Stearoyl-2-Oleoyl-Sn-Glycero-3-Phosphatidylcholine (SOPC) or of a mixture of 90mol%
SOPC and 10mol% N-((6-(biotinoyl)amino)hexanoyl)-1,2-dihexadecanoyl-sn-glycero -3-
phosphoethanolamine (biotin-X DHPE). Dried lipids were resuspended in isopropanol at
2mg/ml and spin coated on the substrate at 2000 rpm for 2 s, followed by 3000 rpm for
30 s. The coated substrate was subsequently dried out in vacuum oven for at least 15min
and then assembled in a microscope chamber, filled with deionized water (DI) and left over
night. In the water the lipids arranged to form a bilayer on top of the substrate. Excess
lipids were washed away by thorough rinsing of the chamber with DI. The DI was then ex-
changed for phosphate buffered saline (PBS). This was carried out so that the bilayer was
never exposed to air as the air-water intersection would immediately destroy the bilayer.
In the case of SLBs with biotin-X DHPE at this point 40µg/ml streptavidin was added to
the chamber and left to incubate for 30min. Subsequently the chamber was rinsed with
DI again and then the DI was replaced by glucose solution.
GUVs were prepared with the electroformation method (compare [6]): Lipids dissolved
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in chloroform (20mol% cholesterol, 40mol% brain sphingomyelin, 40mol% dioleoyl-1,2-
sn-phophatidylcholine (DOPC) and 0.1mol% Texas Red DHPE (1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine, triethylammonium salt at 2mg/ml) were put on indium
tin oxide (ITO) plates and dried out in a vacuum oven. The ITO plates were then assembled
face to face in a watertight Teflon chamber and the space in between was filled up with
sucrose solution. Subsequently an electric field (10Hz, 2V ) was applied for two hours.
During this time the chamber was heated to 40◦C, that is above the phase transition
temperature of the ternary lipid mixture. GUVs were then harvested with a Pasteur
pipette and added to a microscopy chamber filled with glucose solution to a final ratio of
about 1:2 to 1:6.
Small unilamellar vesicles (SUVs) were prepared via extrusion using a mini-extruder
(Avanti Polar Lipids): dried lipids were resuspended in carbonate buffer (1−2mg/ml) and
pressed through micropores of the desired size (200nm or 1µm). A suspension of vesicles
with a very monodisperse diameter formed. Mini-extruder and syringes were washed with
ethanol, DI and buffer prior to use. After use the cleaning procedure was repeated in the
opposite order. For expression of the transmembrane protein ephrin-B2-GFP 8µl SUV
solution, 17.5µl PURExpress cell-free kit and 2µl of ephrin:GFP DNA (131ng/µl) were
mixed and heated to 37◦C for three hours.
3.9 Microstructuring of glass substrates
Microstructures on glass substrates were created using standard photolitography tech-
niques: glass substrates were covered with photo resist, put under a chrome master with
the desired structure and illuminated with UV light. The chrome master exhibited 2µm
wide stripes in 4µm intervals. Subsequently the photoresist was developed and reactive ion
etching (RIE) was used to create the micropattern. Photoresist remains were cleaned off
with piranha solution (3:1 H2SO4/H2O2). Patterns of alternating smooth and rough stripes
were fabricated using borosilicate slides (etching depth of the rough stripes about 30nm).
Groove patterns were fabricated using fused silica slides (groove depth about 1µm).
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Chapter 4
Modeling gene expression dynamics
in a cell-free system
Content of this chapter is the subject of publication [P2] (reproduced by permission of The
Royal Society of Chemistry).
4.1 Quantitative measurements with a cell-free sys-
tem
As described in section 2.1 since their first introduction cell-free systems have been de-
veloped into a versatile tool capable of synthesizing a wide variety of proteins. Even the
notoriously difficult to handle membrane proteins can be synthesized in vitro either with
the use of detergents or by letting them embed into an artificial membrane in situ [9–11].
Another field of application for cell-free systems are microfluidic devices [16, 17]. Cell-free
expression in combination with microfluidics allows for massive parallelization of measure-
ments and can greatly quicken protein interaction studies. This is of interest for example
for identifying and testing new drugs as most drugs target proteins [14]. In the same man-
ner such devices could be used for the detection of toxins for example in food or drinking
water [15]. Furthermore, with this approach one can identify the individual components
of cellular signaling networks and quantify their binding affinities [18, 19].
Beyond purely qualitative work and depending on the actual question being investigated
it is necessary to describe the dynamics of protein synthesis quantitatively. Deterministic
rate equation based models are a standard approach for modeling this kind of biochemical
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reactions. For example Karzbrun et al. presented a rate equation model that describes the
initial rising phase of gene expression in a cytoplasmic E. coli extract [88]. Their model uses
ten free parameters for protein synthesis and degradation rates as well as concentrations of
components. However, this model does not incorporate the late phase of cell-free protein
synthesis when protein levels saturate. Such a saturation can arise either from a steady
state between protein synthesis and degradation or from expiration of the synthesis reaction
due to a lack of resources in the absence of protein degradation. For applications like high
throughput screening where the yield of protein is of interest it is necessary to provide a
model which covers also the late plateau phase.
In the following an ODE model is presented which consistently fits the entirety of
the GFP synthesis kinetics in a reconstituted cell-free system. A set of transcription and
translation measurements was used to calibrate the rate constants in the model to the
cell-free system used. Knowledge of the rates enables the model to predictively describe
protein synthesis dynamics.
4.2 Experimental results
Cell-free GFP synthesis was carried out in 25µl format in a spectrometer cuvette and
the fluorescence signal was recorded as a function of time. This measurement format was
chosen because it offers the necessary sensitivity and dynamic range for a quantitative
evaluation of the data (for more details compare Sec. 3.3). The reconstituted cell-free
system that was used here has the advantage that its composition is well controlled as only
necessary components are included. This is especially important with respect to its lack
of RNAses and proteases (compare sections 2.1.2 and 2.1.3).
GFP expression as a function of DNA First the amount of synthesized GFP as
a function of template DNA was measured. The cell-free system was run with DNA
concentrations between 0.3 pM and 30nM , that is five orders of magnitude, and the kinetics
of GFP synthesis was recorded as shown if Fig. 4.1. The GFP levels rise linearly in the
first 3h and reach a plateau afterwards. The individual slopes as well as GFP yields are
inherent to the respective template DNA concentration up to a concentration of about
1nM . At this point the protein synthesis machinery is saturated and additional template
is not processed as shown in Fig. 4.2. A maximum GFP synthesis rate of about 200nM/h
and a maximum GFP yield of about 300nM was found.
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Figure 4.1: Cell-free synthesized GFP as a function of different plasmid DNA concentra-
tions. A) shows the data in a linear graph and B) in semilogarithmic representation. With
higher DNA concentrations GFP levels grow faster. Note that GFP levels start to saturate
after about three hours in all cases, however at different plateau levels. The lines depict
the best concurrent fit of the model to the data (see text for details).
The data in Fig. 4.1 show that the final GFP yield is a function of template DNA
in the linear regime. However, the observed plateaus can not simply be explained by an
expiration of the GFP synthesis reaction due to the exhaustion of some resource like NTPs
or amino acids. Under this assumption the reaction should expire after the same amount of
GFP had been synthesized regardless of DNA concentration. Less template should simply
lead to a slower rise to this universal GFP level.
The different plateaus can also not be explained as a steady state between GFP syn-
thesis and degradation like in the in vivo case described in chapter 5. As advertised by the
manufacturer the PURE reconstituted cell-free system should be essentially free of RNAse
and protease. Indeed in the measurements of GFP maturation described further below no
GFP degradation was observed.
Expiration of cell-free GFP synthesis Expiration at different GFP plateau levels
can be explained by the hypothesis that some key component of the cell-free system like
polymerases, ribosomes or NTPs degrades during the first 3h after initiation. The PURE
system is stored as aliquots of two solutions ”A” and ”B” at −80◦C. As such it is stable for
at least six month. Initiation of a measurement means that the two solutions are mixed,
DNA is added and the temperature is set to 37◦C. In order to check this hypothesis a
timing measurement was carried out: aliquots of cell-free system were activated by mixing
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Figure 4.2: A) GFP synthesis rate and B) maximum yield as a function of template DNA.
Higher concentrations of DNA template lead to faster synthesis as well as higher yield
of GFP. However, at about 1nM DNA the cell-free machinery begins to saturate in a
Michaelis-Menten like manner. The red curves depict a Michaelis-Menten fit to the data
shown to guide the eye.
and heating. A fixed amount of DNA was added at different time points and the resulting
kinetics of GFP synthesis were recorded (Fig. 4.3). With increasing delay time continuously
lower yields of GFP are obtained. In agreement with the measurements depicted in Fig.
4.1 the cell-free system becomes inactive after a delay time of about 3h.
In the following it was aimed to identify the exact component that is degraded. It
has been shown that in cytoplasmic extracts NTP hydrolysis, accumulation of inorganic
phosphate and degradation of enzymes can play a role in the expiration of protein synthesis
[51, 89, 90]. The longer life time of the transcription step compared to the complete protein
synthesis reaction shown further below in Fig. 4.5 implies that the sought after component
is part of the translation step (GFP maturation does not involve components of the cell-free
system). NTP hydrolysis was ruled out as the cause for the expiration of GFP synthesis as
addition of fresh NTPs in 4mM concentration (about two times the concentration in the
PURE system) in the plateau phase more than 3h after initiation did not restore protein
production. However addition of 2.6µM fresh ribosomes (2.4µM ribosomes are included
in the PURE system) did indeed restore GFP synthesis. In this case the GFP level reached
180% of the usual yield (see Fig. 4.4).
Transcription rate In the next step the transcription rate was measured individually.
This required some sort of label for the mRNA. Karzbrun et al. [88] used radioactive
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Figure 4.3: Unspecific degradation of the cell-free system leads to GFP plateaus as a
function of DNA concentration (compare text). This effect was quantified as follows: a
fixed amount of DNA was added to the cell-free system with different delay times. With
growing delay time the final yield of GFP decreased (A). After about three hours delay
time cell-free expression had ceased. The curves in (A) show the best concurrent fit of the
model to the data (see text for details). The red curve in (B) was added to guide the eye.
Figure 4.4: Measurements were undertaken to identify the exact limiting component of
the cell-free system that causes the observed cessation of the GFP synthesis reaction after
three hours: from the data shown in Fig. 4.5 it is known that cell-free transcription is not
affected by this degradation of performance after three hours. Therefore a component of the
translation step must be affected. After more than three hours of GFP expression (black
squares) fresh resources were added to the sample. NTPs are a typical target of unspecific
hydrolysis in cell-free systems. However, fresh NTPs did not restart GFP synthesis (blue
triangles). On the other hand, fresh ribosomes did restart GFP production such that a
final yield of 180% of GFP was achieved (red dots).
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nucleotides for mRNA labeling in cytoplasmic E. coli extract. Osada et al. [91] applied
”Quant-iT RiboGreen” fluorescent RNA dye for RNA labeling in a ”transcription only”
solution. However, radioactive labeling was not available and it was found that the Ri-
boGreen dye produced a high background noise in the cell-free transcription/translation
system which was attributed to fluorescent markers binding to tRNAs. This prevented
the non ambiguous detection of mRNA synthesis. Therefore another approach was chosen:
specific labeling of mRNA using molecular beacons (compare Sec. 3.5 for details). In the
presence of a complimentary strand - in this case the mRNA - molecular beacons uncurl
from the closed hairpin state and bind to the mRNA. This results in a fluorescence signal
of the FRET fluorophores. Cell-free mRNA synthesis measured this way is depicted in Fig.
4.5 A. The transcription life time depends on DNA concentration unlike translation which
universally expires after 3h. At 6.8nM DNA transcription expires after about 6h whereas
at 1.7nM and lower concentrations it continues for over 8h. Note that transcription there-
fore outlives cell-free translation. It is also interesting to note that mRNA levels in the
cell-free system exceed GFP levels (compare Fig. 4.5 A and 4.5 B). From this follows that
not all mRNAs are successfully translated into GFP. No significant mRNA degradation
was observed in the PURE system.
GFP maturation rate GFP has to fold into its correct three-dimensional conformation
before its fluorophore becomes active (compare Sec. 2.4.2). This time limiting maturation
step was measured by inactivating the ribosomes in the first 3h of protein synthesis. An
increase of measured GFP fluorescence after this time point is due to maturation of already
synthesized protein (Fig. 4.6). This relaxation of GFP levels was fitted with an exponential.
The obtained GFP maturation time is tmat = 5.0 ± 0.7min and the maturation rate is
therefore 0.2min−1. This value is in good agreement with a maturation time of 6.5min
which was reported for GFP maturation in E. coli [92].
Looking at late times after ribosome inactivation no decrease of the GFP abundance
was observed meaning that protease activity was insignificant in the reconstituted cell-free
system.
Comparison with other cell-free systems It is of interest to know if insights gained
from the PURE system can suitably be carried over to other cell-free systems as well.
Therefore GFP expression kinetics were measured in an eukaryotic extract (based on rabbit
blood) and in an E. coli extract (Fig. 4.7). Here GFP synthesis expired somewhat sooner
than in the reconstituted system, that is after about 2h compared to 3h and the final GFP
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Figure 4.5: Transcription rate in the cell-free system measured individually: molecular
beacons complementary to the mRNA were added to the sample. These beacons carry
the fluorophore Cy5 which only fluoresces in the bound state because of quenching in
the unbound state. A) depicts the kinetics of mRNA synthesis as a function of DNA
concentration. In B) the corresponding curves of GFP synthesis are shown for comparison.
As can be seen cell-free transcription lasts longer and reaches higher values than translation.
Note also that in A) the time point at which transcription saturates depends on the DNA
concentration: at higher concentrations mRNA levels saturate earlier. The lines in A)
depict the best concurrent fit to the data according to the model (see text for details).
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Figure 4.6: The GFP maturation rate measured individually: during the rising phase of
cell-free GFP expression the antibiotic chloramphenicol was added to the sample. This
inactivates the ribosomes and residual increase of GFP fluorescence after this time point
is due to GFP maturation. This increase in fluorescence can be fitted with an exponential
and the maturation rate be extracted (a cartoon of the measurement principle is shown on
the left, actual data on the right).
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Figure 4.7: In order to verify the insights gained from studying the PURE cell-free system
an E. coli based extract as well as an eukaryotic extract were quickly analyzed (3.4nM
of template DNA was used, compare with Fig. 4.1 A). It was found that overall the GFP
synthesis kinetics of these extracts exhibit a similar shape compared to the PURE system
albeit the GFP yield is somewhat lower and the reaction terminates already after two
hours.
abundance was approximately one order of magnitude lower. Noticeably, GFP synthesis
was not restarted by introducing fresh ribosomes in the plateau phase as it was the case
with the PURE system.
4.3 Concurrent fit with a rate equation model
The objective in modeling was to develop a predictive model of cell-free transcription/trans-
lation. To this end a concurrent and quantitative fit to the calibration measurements
shown in Figs. 4.1, 4.3 and 4.5 was created. A standard ODE based approach containing
rate equations for transcription, translation and maturation was used. This scheme was
complemented with finite resources for the transcription and translation step respectively
(see Fig. 4.8). When developing the model the main focus was to keep the number of free
parameters as small as possible while still concurrently fitting:
• early and late phase traces of GFP synthesis dependent on DNA concentration (Fig.
4.1)
• saturation of protein yield at about 1nM DNA concentration (Fig. 4.2)
• expiration of translation after 3h independent of DNA addition (Fig. 4.3)
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Figure 4.8: Rate model of cell-free GFP synthesis. Both transcription and translation
consume energy and raw materials out of the finite pools of resources in the samples. The
resources also degrade independently of the protein synthesis reaction. Degradation also
limits the mRNA life time whereas GFP is stable over the course of one measurement.
These considerations led to the following model:
d
dt
mRNA =
kts · TsR ·DNA
Ks +DNA
− δmRNA ·mRNA
d
dt
GFP =
ktl · T lR ·mRNA
Kl +mRNA
− kmat ·GFP
d
dt
GFP ∗ = kmat ·GFP
d
dt
TsR = −kcs · TsR ·DNA
Ks +DNA
d
dt
T lR = − δT lR · T lR
KT lR + T lR
(4.1)
(4.2)
(4.3)
(4.4)
(4.5)
For transcription and translation Michaelis-Menten like equations were applied in order
to account for the observed saturation effect. During model development mass-action
kinetics as well as Hill functions were tested for transcription and translation. However,
it was found that it is not possible to properly fit the GFP traces over all five orders of
magnitude of DNA concentration with mass-action kinetics. That is only either low or
high concentrations could be fitted satisfactorily but not both simultaneously. On the
other hand Hill equations for transcription and translation produced a good fit to the
entirety of the data. However, the optimized fits returned Hill coefficients very close to one
which means that the Hill equations were basically reduced to the Michaelis-Menten like
equations (4.1) and (4.2) shown above.
The prefactors TsR and T lR account for the observed expiration of GFP synthesis
after 3h. They stand for the resource pools of molecules of the transcription and trans-
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Parameter Model result Previous studies Ref.
kts 18.2nM/min = 2.2NTP/s 250NTP/s (in vivo) [93]
ktl 16.1nM/min = 0.03 aa/s 1.8 aa/s [20]
kcs 1.1 · 10−2 n/a
δmRNA 7.8 · 10−4/min 8.3 · 10−2/min [88]
δT lR 4.5 · 10−3/min n/a
Ks 8.5nM 0.8− 4.2nM [94]
Kl 65.8nM 14− 30nM [95]
KT lR 6 · 10−5 n/a
Table 4.1: Optimized fit parameters and literature values given for comparison.
lation step respectively like polymerases, NTPs, ribosomes, tRNAs and so forth. This
simplification is necessary since the exact concentration of the individual molecules is not
known. This also means that meaningful initial values for TsR and T lR could not be de-
duced. They were therefore set to one and scaling parameters were installed. During model
development two manners of consumption of TsR and T lR were studied: first, degrada-
tion independent of transcription and translation respectively and second, consumption by
transcription/translation. Thus the preliminary rate equations for TsR and T lR were:
d
dt
TsR = −kcs · TsR ·DNA
Ks +DNA
− δTsR · TsR
KTsR + TsR
(4.6)
d
dt
T lR = −kcl · T lR ·mRNA
Kl +mRNA
− δT lR · T lR
KT lR + T lR
(4.7)
In either equation the first term represents consumption of the resources and the sec-
ond term resource degradation. The parameters kcs, δTsR, kcl and δT lR were optimized
simultaneously with the other fit parameters of the model. Thus the optimal value of
δTsR was found to be close to zero after multiple optimization steps. Hence degradation of
TsR independent of transcription was omitted from the final model. Analogously it was
found that kcl had its optimum close to zero and consumption of T lR was consequently
omitted. Thus the rate equations for TsR and T lR were implemented into the final model
in the form of equations (4.4) and (4.5). The time course of TsR and T lR exhaustion as
implemented in the model is shown in Fig. 4.9.
By means of the model (eqs.(4.1)-(4.5)) a concurrent fit to the data of transcription and
translation was created. First a numerical solution of the rate equations was fitted to the
data using a downhill simplex algorithm followed by least squares minimization. The eight
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Figure 4.9: DNA dependent consumption of transcription resources TsR and DNA in-
dependent degradation of translation resources T lR as predicted by the model. Because
the exact composition of the resources as well as their amount is not known the starting
amount was set to one and scaling parameters were introduced.
free fit parameters of the model were weighted equally. Subsequently a Bayesian ensemble
of the parameters was created using a Markov chain Monte Carlo method. The variance of
each parameter value was found to be small indicating that a stable fit was reached. The
optimum fit is represented by the solid lines in Figures 4.1, 4.3A, 4.5A (see also Tab. 4.1
for the optimum fit parameter values).
The transcription and translation rates are lower than their in vivo values. This ob-
servation is in agreement with data from Karzbrun et al. [88] who reported a similar
drop for an E. coli based cell-free extract. Here the transcription rate of T7 polymerase
is 2.2NTP/s while the in vivo value is 250NTP/s. The translation rate of 0.03 aa/s
obtained from the fit is also lower than it has been originally estimated for the PURE
system. The constants kcs, δT lR and KT lR which are associated with the notion of finite
resources TsR and T lR have no counterpart in previous literature. δmRNA is two orders of
magnitude lower than reported for a cytoplasmic E. coli cell-free extract. This is reason-
able as the reconstituted system is essentially free of RNAses and proteases. Consequently
no proteolytic degradation of GFP was observed. The obtained values for the Michaelis
constants Ks and Kl are comparable to values found in previous literature.
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4.4 Discussion
Cell-free systems were originally developed as a convenient means to synthesize proteins
that are hard to produce in cells like toxic proteins. Nevertheless due to their comparative
simplicity and ease of modification they also exhibit great potential as in vitro model plat-
forms for transcription/translation studies. This however necessitates knowledge of kinetic
parameters, expected protein yield, necessary template DNA concentration and reaction
speed of the particular cell-free system which is generally not provided. Here a procedure
of how to specify gene expression dynamics of a cell-free system through a combination of
a set of calibration experiments and a mathematical model is established. The presented
model concurrently fits the entirety of the data with one set of eight parameters. This
was achieved by expanding the classical rate equation scheme as it is known from work
in vivo (chapter 5) in two key points: first, a Michaelis-Menten like ansatz to account for
saturation at high DNA concentrations and second, finite resource pools for transcription
and translation. In this manner the model presented here adequately captures both the
early rising phase and the late plateau phase of cell-free protein synthesis. It does so con-
sistently over five orders of magnitude of DNA concentration with one set of fit parameters.
After calibrating the model to the respective cell-free system used in an experiment the
model predictively describes time courses of mRNA and protein synthesis as a function of
template concentration and experimental timing. The fact that here a more general model
(Hill formalism for protein synthesis and two different decay processes for transcription and
translation resources) was reduced to a simpler form solely through parameter optimization
of simulated values to experimental data is quite remarkable. In principle a more general
formalism should result in a better fit because of the trade-off between model simplicity
and fit quality. Here the experimental data seem to be well suited for discriminating the
models and support the simplification. Note however that in the case of significant RNAse
or protease activity in a particular cell-free system the more general expressions (4.6) and
(4.7) for TsR and T lR time courses have to be tested.
In many applications of cell-free systems a protein yield as high as possible is desired.
It is therefore of great interest to know the exact cause of cessation of protein synthesis in
a specific system. Through careful analysis of the data the translation step was identified
as the bottle neck in the PURE system. It was found that in the reconstituted system
accumulation of inorganic phosphates or NTP hydrolysis are not problematic as protein
synthesis could simply be restarted by introducing fresh ribosomes to the sample. In this
manner a protein yield of 180% of the yield without ribosome replenishment could be
54 4. Modeling gene expression dynamics in a cell-free system
achieved. This insight might prove to be valuable as a strategy for improved protein yield:
it is more cost efficient to add fresh ribosomes to a sample with correct timing instead of
doubling the sample volume. However, it was found that this is not necessarily true for
any cell-free system. Fresh ribosomes did not restart GFP synthesis in two systems that
were tested (based on rabbit blood and E. coli extract respectively).
The combination of a cell-free system with properly characterized transcription/trans-
lation kinetics and a predictive mathematical model is a valuable tool for quantitative
studies of gene expression kinetics, regulatory networks, modifications of individual com-
ponents or the specific effects of drugs. It should be noted that the measurements presented
here were performed in bulk format (on the order of ten to twenty micro liters) meaning
that even at the lowest concentration presented here on the order of 103 DNA or mRNA
molecules were present in a sample. This is markedly more than the numbers found in
vivo (using micro containers in a microfluidics setup these numbers could be downscaled
to typical cellular values, compare the outlook). Furthermore, the components of cell-free
systems compared to living cells are diluted by a factor of two and the composition is of
course much less complex. Therefore, in the following chapter an artificial system is stud-
ied that is more alike to natural cells: the GFP expression kinetics of mRNA and pDNA
transfected cells. Than in chapter 6 a modification is introduced into the cell-free system
and the GFP expression kinetics of the modified system are compared to the unmodified
one.
Chapter 5
Modeling of exogenous gene
expression in eukaryotic cells
The content of this chapter is the subject of the manuscript [M1]. Flow cytometry and
quantitative fluorescence microscopy measurements reported in this chapter were per-
formed by Carolin Leonhardt and Gerlinde Schwake.
5.1 From in vitro to in vivo modeling of gene expres-
sion
Cell-free protein synthesis is overall an artificial process despite the fact that these systems
are composed of components that are mostly part of the cellular gene expression machinery.
It is therefore of great interest to verify that the modeling approach described in chapter 4
is also applicable in vivo. Transfection of cells is a natural choice for a rate equation based
modeling approach. The expression of such exogenous genes is not controlled by the cellular
gene regulation network. Their expression dynamics therefore follows a deterministic profile
as it is described by a rate equation model. Furthermore, transfection of cells can be
performed both with DNA as well as mRNA vectors. From a modeling perspective this
is advantageous because it allows examination of the translation process independently of
transcription.
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Figure 5.1: Transfection of an eukaryotic cell with exogenous genetic information using a
cationic lipid agent. A) pDNA loaded vectors need to pass both the cell membrane as well
as enter the nucleus to deliver their cargo. B) mRNA vectors on the other hand deliver
their cargo directly into the cytosol. C) The pDNA vector used in this study carries the
eGFP sequence under control of a CMV promoter. D) The mRNA was synthesized in
vitro using a plasmid which was specifically designed with maximal possible analogy to the
pDNA vector. The biggest difference between both mRNAs is that the in vitro mRNA
carries an anti-reverse cap analog (ARCA) at its 5’-end as well as a poly(A) tail and an
untranslated region (UTR) at its 3’-end. This enhances its translation rate as well as its
stability against enzymatic degradation respectively.
5.2 Transfection of cells with synthetic pDNA and
mRNA lipid vectors
Transfection of cells that is the introduction of an exogenous gene into the cell, is usually
done with plasmid DNA (pDNA) as carrier of the genetic information. However, it is also
possible to use mRNA instead which has certain advantages. In the case of eukaryotic cells
a mRNA vector only has to deliver its cargo to the cytosol and does not need to enter the
nucleus as shown in Fig. 5.1 (compare also Sec. 2.2). The probability of nuclear entry
depends on the cell cycle, it is highest when the cell is close to mitosis. pDNA transfection
is therefore inefficient for non-dividing cells whereas mRNA transfection is independent
of the cell cycle [96–98]. Furthermore, with mRNA transfection there is no risk that the
new genetic information is permanently integrated into the genome of the cell. A third
advantage is that the immunoreaction of cells to mRNA transfection was observed to be
less severe compared to pDNA transfection [99, 100].
Especially in the context of clinical applications gene delivery to eukaryotic cells re-
mains a challenging task. Synthetic cationic lipid based vectors have been developed as a
quantitative and predictive alternative to viral gene delivery. Mathematical modeling of
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the statistical gene delivery process and the gene expression kinetics can help to further
the understanding of transcriptome dynamics as well as RNA based devices.
Here transfection of a cell culture with pDNA and mRNA vectors (Fig. 5.1 C, D)
respectively was quantitatively measured and compared. Identical preparation protocols
were followed for both vector types in order to guarantee comparability of the results.
Both pDNA and mRNA encoded eGFP so that fluorescence microscopy in combination
with automated image analysis could be used to measure the gene expression kinetics at
the single cell level. Arbitrary fluorescence units were converted into numbers of GFP per
cell using the calibration standard described in Sec. 3.4.
Figure 5.2 A)-C) shows flow cytometry data of three different cell lines 22 hours after
transfection (sidewards scatter vs. fluorescence signal). All three cell lines feature non-
transfected as well as transfected cells after both pDNA and mRNA transfection. These
populations correspond to the two different “clouds” of cells visible in each graph. pDNA
transfection uniformly generates cells with higher eGFP fluorescence compared to mRNA
transfection. That is the cloud of pDNA transfected cells is shifted farther to the right than
the cloud of mRNA transfected ones. This effect can be more clearly seen in a histogram
representation of the fluorescence data (Fig. 5.2 D)-F), pDNA data in red and mRNA data
in blue).
Flow cytometry measurements offer the advantage that a great number of cells can be
studied at once (here 15’000 cells per measurement) which yields good statistics. However,
this comes at the prize that data are only taken at a specific point of time (here 22h after
transfection). For this reason quantitative fluorescence microscopy was used as an addi-
tional technique in order to record single cell time traces of pDNA and mRNA transfected
cells (see Fig. 5.3). These data more clearly disclose differences between pDNA and mRNA
transfection than flow cytometry data. In Fig. 5.3 A, B an overlay of eGFP fluorescence
and brightfield images of transfected cells is shown. The fraction of transfected cells was
61% for mRNA and 40% for pDNA transfection. In Fig. 5.3 C, D single cell time traces are
depicted. These reveal that the onset time of GFP expression ton after mRNA transfection
is strongly centered around 2h ± 1h after transfection whereas expression after pDNA
transfection starts anywhere from 2h to 20h after transfection. mRNA transfection yields
a steady rise in eGFP fluorescence levels until a maximum is reached and the fluorescence
levels begin to decline due to mRNA degradation. pDNA transfection on the other hand
yields sigmoidal shaped fluorescence time courses which result in a steady state of cellular
eGFP levels.
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Figure 5.2: A)-C) show scatter plots of three different cell lines created from flow cytome-
try data of pDNA and mRNA transfection (sidewards scatter vs. fluorescence signal). The
two distinct “clouds” of cells in each graph correspond to non-transfected cells and trans-
fected cells respectively. The red line indicates the corresponding signal of a fluorescence
standard at the various gain settings. D)-F) show histograms of fluorescence data. pDNA
transfection (red) clearly generates higher fluorescence per transfected cell than mRNA
transfection (blue). G)-I) Comparison of the percentage of transfected cells of pDNA and
mRNA transfection for the various cell lines.
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Figure 5.3: A) and B) show an overlay of bright field and fluorescence images of mRNA
(A) and pDNA (B) transfected cells about 25h after transfection. Scale bars are 100µm.
C), D) The GFP expression kinetics of pDNA and mRNA transfected cells respectively
show clearly distinct behavior. mRNA transfected cells uniformly start expression at a
reasonably well defined time point about 2h after transfection. The onset time of expression
in pDNA transfected cells on the other hand exhibits a considerably wider distribution.
Note also that the maximal slope of pDNA transfected cells is markedly higher than in the
case of mRNA transfection.
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Rates in h−1 mRNA vector pDNA vector Ref.
Transcription rate kTS n/a 180 [56, 101]
Translation rate kTL 180 100 [25, 56]
mRNA degradation rate δ - 0.1 [56, 102]
GFP degradation rate β 0.035 0.035 [56, 102]
Table 5.1: Literature values for protein production and degradation rates. The mRNA
vector was designed in the framework of this study therefore no literature value is available
for its degradation rate. The 1.8 times higher translation rate of the in vitro mRNA
compared to the in vivo mRNA is due to its ARCA cap.
5.3 Analytical expression of GFP synthesis
The synthesis of eGFP in transfected cells can be described using a differential equation
based model with continuous rates for transcription, translation, maturation and degrada-
tion. Literature values of these rates are depicted in Tab. 5.1. The in vitro transcribed
mRNA that was used in the mRNA vector carries a cap analog on the 5′ end which in-
creases the translational efficiency [103]. The in vitro mRNA is also more stable against
degradation therefore the literature value for δ cannot be applied. The simplest math-
ematical model of eGFP synthesis using ordinary differential equations (ODEs) looks as
follows:
d
dt
m = kTSP − δm (5.1)
d
dt
G = kTLm− βG (5.2)
Here m, P and G denote the number of mRNA, pDNA and eGFP respectively. Note
that degradation of pDNA is not included in the model as pDNA is expected to be stable
over the course of one measurement (measurement time is up to 25h) [104]. Furthermore,
a eGFP maturation term was omitted from the model in order to keep the mathematical
expression as simple as possible. This was validated by fitting exemplary traces with a
model containing the maturation step and the one without described here. The discrepancy
in the resultant fit parameters was found to be negligible. This model can be solved
analytically. Using the initial condition that at time point zero no mRNA and no eGFP
has yet been synthesized that is m(0) = G(0) = 0 one obtains the following solution for
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eGFP synthesis as a function of time for the case of pDNA transfection:
GDNA(t) =
kTSkTLP
βδ(δ − β)
[(
1− e−β(t−ton)) δ + (−1 + e−δ(t−ton)) β] (5.3)
Note that in equation (5.3) the time axis was shifted by ton which accounts for the onset
time of eGFP expression. Equation (5.3) reaches a steady state between eGFP synthesis
and degradation over long times due to the lack of pDNA degradation:
lim
t→∞
GDNA(t) =
kTSkTLP
βδ
(5.4)
In the case of mRNA transfection the transcription term in equation (5.1) can simply
be omitted. Using the initial condition m(0) = m0 and G(0) = 0 where m0 denotes the
number of mRNA molecules that were delivered to the cell the resulting expression for
eGFP synthesis after mRNA transfection reads:
GmRNA(t) =
kTLm0
δ − β
[
1− e−(δ−β)(t−ton)] e−β(t−ton) (5.5)
The initial slope of equation (5.5) correlates to the maximal GFP synthesis rate in the
cell. It is given by:
G′(0) = kTLm0 (5.6)
5.4 Mathematical analysis of pDNA and mRNA vec-
tor expression kinetics
pDNA model The expression (5.3) was applied to fit eGFP expression time traces of
pDNA transfected cells. However, it was found that the dynamics could not be fitted us-
ing rates for protein production and degradation that are in accordance with the literature
values listed in Tab. 5.1. Using fit parameters with values that are in accordance with pre-
vious literature the resulting model curve rises markedly shallower than the experimental
data. This is depicted in Fig. 5.4 A. The red curve was created applying equation (5.3)
with fixed parameter values from Tab. 5.1 and the mean value of pDNA molecules per
nucleus for these curves obtained from equation (5.4). In order to fit the steep rise in GFP
levels unrealistically high values for eGFP production and degradation rates would have
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Figure 5.4: A) The pDNA model does not fit the data within the constraints of the
literature values of Tab. 5.1. With these parameter values the steepness of the resulting
curve is much too shallow to adequately fit the data. Note that the fluorescence levels were
normalized and all curves were shifted by ton. B) An acceptable fit as shown here can only
be obtained using unrealistically high rates for GFP synthesis and degradation (about one
to two orders of magnitude higher than literature values, compare the parameter values
depicted in the box with the literature values in Tab. 5.1).
to be employed (about one to two orders of magnitude higher than literature values, see
Fig. 5.4 B). However, despite its failure to accurately capture the early dynamics of GFP
synthesis the expression for large t (equation (5.4)) can be used to fit the steady state
between eGFP production and degradation and thus obtain the number of transfected
pDNA molecules per cell. This number was found to be on the order of ten which is in
good agreement with previously published data [56].
mRNA model Equation (5.5) was used to fit single cell traces of mRNA transfected
cells. Unlike with pDNA mentioned above here the eGFP expression kinetics could be
adequately fitted with parameter values that were in the established range of previous
literature. Free fit parameters were the product of the translation rate and the number of
transfected mRNA molecules kTL ·m0, the degradation rates for mRNA and eGFP δ and
β as well as the onset time ton. The mRNA model captures well both the initial rise of
GFP levels and the late decrease due to degradation of mRNA and eGFP as shown by the
exemplary fits depicted in Fig. 5.5 A. Normalizing the fluorescence levels and shifting by
ton reveals that the time courses of mRNA transfected cells collapse on one master curve
whereas normalized and shifted pDNA curves show no such generic behavior (compare
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Figures 5.4 A and 5.5 B).
The fit parameter distributions obtained by fitting traces of 283 mRNA transfected cells
are shown in Fig. 5.5 C-F. In Fig. 5.5 C the distribution of ton for pDNA transfected cells
(in red) is given for comparison. The distributions of the degradation rates δ and β were
fitted with a Gaussian1. This yields δ = 0.056± 0.021h−1 and β = 0.051± 0.022h−1. This
is slightly bigger than a value of 0.028h−1 for δ reported previously [105]. The result is
smaller than the degradation rate of endogenous mRNA (0.1h−1) which was to be expected
due to the stabilizing cap that the in vitro mRNA carries. Note that in the model kTL
and m0 are linked and therefore only the product of both appears as a fit parameter (Fig.
5.5 D). However, the number of mRNA molecules that are successfully transfected per cell
would be of great interest. Since transfection is an inherently stochastic process it can be
assumed that the greater part of the observed variance of kTL ·m0 is due to an underlying
distribution of m0 and not due to great variability of kTL. Therefore, in the following
section a stochastic mRNA delivery model will be developed to account for this variance.
5.5 Stochastic mRNA delivery model
The assumed mRNA delivery process to transfected cells is depicted in Fig. 5.6. mRNA
and the lipid mixture lipofectamine form complexes with on average m mRNA molecules
per complex. These complexes sediment on to the cells and are taken up via the endocytotic
pathway with on average N endosomes per cell. The complexes then escape the endosomes
with a lysis probability k and are unpacked with probability q. Afterwards the freed mRNA
molecules are available for translation.
The number of endosomes as well as the number of complexes in an endosome are
assumed to be small and to arise from stochastic and independent processes. Therefore,
Poisson distributions are adopted for both. The probability to have N endosomes in a
given cell is then described by:
PN(k) =
Nk
k!
e−N (5.7)
Endosomes lyse with probability k. The probability distribution of N ′ lysed endosomes
is a convolution of eq. (5.7) with a binomial with probability k since lysis can happen for
1The Gaussian or normal distribution is given by f(x) = 1
σ
√
2pi
e−
(x−µ)2
2σ2 where µ is the mean and σ the
standard deviation.
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Figure 5.5: A) single cell traces of mRNA transfected cells; B) traces from A) shifted by
ton and normalized; C) distribution of ton for pDNA (red) and mRNA (blue) transfected
cells; D)-F) distributions of independent fit parameters of 283 analyzed A549 single cell
traces (mRNA transfection). Refer to the text for details.
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Figure 5.6: It is assumed that lipoplexes are taken up by the cell via the endocytotic path-
way. First, lipoplexes sediment on to the cell membrane. Then the membrane invaginates
around these lipoplexes and is chocked off creating an endosome with the lipoplexes inside.
Subsequently the endosome lyses and the mRNA molecules are released into the cytosol. In
the context of the stochastic delivery model described here it is assumed that the average
number of endosomes per cell N as well as the average number of lipoplexes per endosome
c are small. Therefore, N and c follow Poisson distributions.
all N ≥ N ′:
P (k|N ′, N) =
(
N
N ′
)
kN
′
(1− k)N−N ′ · PN(k) (5.8)
Equation (5.8) can simply be reduced to a Poissonian with the parameter Nk. As
motivated above the probability distribution of complexes per endosome is also a Pois-
sonian with parameter c. The probability to have c′ complexes from lysed endosomes in
a cell is then a convolution of both processes. Using the fact that a convolution of N ′
Poisson distribution with parameter c is itself a Poisson distribution with parameter N ′c
and accounting for all possible values of N ′ yields:
P (c′) =
∞∑
N ′=0
(Nk)N
′
N ′!
e−Nk
(N ′c)c
′
c′!
e−N
′c (5.9)
In the above equation it is implied that all complexes are identical which is an unrealistic
assumption. One would rather expect that the complex size and therefore mRNA payload
to follow a normal distribution. This means a convolution of equation (5.9) with a normal
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Figure 5.7: A) Probability distribution of mRNA transfected A549 cells at various mRNA
concentrations generated from flow cytometry data. At higher concentrations the fraction
of transfected cells increases but not the average fluorescence per cell (the position of the
peak does not shift to the right). B) Fraction of transfected cells generated by integrating
the data from (A). A stochastic mRNA delivery model with only one Poisson process does
not satisfactorily fit the data (dashed red line). However, the model with two independent
consecutive Poisson processes (equation (5.10)) presented in the text does (blue line). Here
the fit parameters are N ′ = 0.9± 0.2 and c′ = 1.1± 0.5.
distribution.
A further quantity of interest is the transfection ratio, that is the percentage of trans-
fected cells at a given concentration of lipoplexes (that is mRNA) in the cell culture. This
is the probability that in a cell at least one lipoplex is released from the endosomes (note
that here the unpacking probability of complexes q in Fig. 5.6 is assumed to equal one
for simplicities sake). The transfection ratio is obtained by summing over eq. (5.9) from
c′ = 1 to infinity:
P (c′ ≥ 1) = 1− exp[N ′(e−c′ − 1)] (5.10)
In Fig. 5.7 A the probability distributions of A549 cells transfected with various con-
centrations of mRNA are depicted. The data were recorded using flow cytometry. Higher
concentrations of mRNA increase the number of transfected cells. However, interestingly
the average brightness of the cells does not increase (that is, the peak in Fig. 5.7 A is
not shifted to the right at higher mRNA concentrations). The dose response relationship
between mRNA concentration and fraction of transfected cells is depicted in Fig. 5.7 B. It
was obtained by integrating the probability distributions in Fig. 5.7 A. The fact that only
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Figure 5.8: Distribution of mRNA molecules per transfected cell m0 obtained by dividing
the distribution of kTLm0 in Fig. 5.5 D by the literature value kTL = 180h
−1. The fit (blue
line) was obtained by inserting N ′ = 0.9 and c′ = 1.1 into equation (5.9) and convolving
with a normal distribution. This is necessary to account for a distribution in complex size
and therefore mRNA payload. The fit parameters are the standard deviation σ = 2 and
the average number of mRNA molecules per complex NmRNA = 300.
up to 60% of all cells are transfected indicates that some bottleneck in the transfection
process limits this number. The simplest model of such a bottleneck would be a single
Bernoulli process2 with a low probability of success. The resulting probability distribution
would then be a Poissonian and the dose response relationship would therefore feature a
simple exponential increase. This case is depicted with the doted red line in Fig. 5.7 B. Ob-
viously, this model does not yield an acceptable fit to the data. An acceptable fit however
can be obtained by inwoking equation (5.10) of the double Poissonian model discussed
above (blue line in Fig. 5.7 B). The fit returns the average number of lysed endosomes
N ′ = 0.9± 0.2 as well as the average number of unpacked complexes c′ = 1.1± 0.5.
Using equation (5.9) the model can furthermore reproduce the probability distribution
of successfully transfected mRNA molecules per cell m0. In Fig. 5.8 the distribution
of m0 of 283 A549 cells obtained with quantitative fluorescence microscopy and image
analysis is depicted. Note that these are the same data as shown previously in Fig. 5.5 D
albeit divided by kTL = 180h
−1 (see Tab. 5.1). When comparing these data with the
predicted distribution of equation (5.9) with N ′ = 0.9 and c′ = 1.1 it was found that the
predicted distribution is narrower than the one obtained from single cell data. However, if
one assumes that the complex size follows a normal distribution one obtains the standard
2In probability theory a Bernoulli process is a discrete stochastic process which has only two possible
states – success and failure.
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deviation σ as a fit parameter that broadens the distribution. The second fit parameter is
the average number of mRNA molecules per complex NmRNA. The fit depicted in Fig. 5.8
was obtained with σ = 2 and NmRNA = 300.
5.6 Analysis of mRNA and pDNA vectors with FCS
In this section it shall be explained that the mRNA package size of 300 mRNA molecules
obtained above is reasonable. To this end the average size of the lipoplexes was measured
with FCS. Subsequently, an estimation of mRNA payload based on charge neutrality be-
tween negatively charged nucleotides and positively charged lipid analogues is presented.
mRNA was complexed with lipofectamine according to the same protocol as with trans-
fection experiments with the modification that Sybr Gold was added as a fluorescent tag.
After 30min of incubation at room temperature the average hydrodynamic radius of the
lipoplexes was determined with FCS. The hydrodynamic radius of free mRNA was mea-
sured for comparison (see Fig. 5.9 A, B). For the formulas used here compare section 3.2.
The average hydrodynamic radius of mRNA lipoplexes was 46nm− 70nm (8nm for free
mRNA). The same analysis was performed for pDNA lipoplexes and similar values were
measured meaning that mRNA and pDNA lipoplexes have on average the same size.3
For simplicity’s sake it is assumed that the lipoplexes have a cubic shape with an edge
length twice the hydrodynamic radius. The concentration of cationic lipid analog DOTAP
in the commercial transfection medium Lipofectamine is not known but typical transfection
media have a concentration of about 50%. Therefore, this value is also used here. Previous
studies established that cationic lipid/nucleic acid complexes exhibit alternating layers
of lipids and nucleic acids with a repeat distance of 65 A˚as shown in Fig. 5.9 C [106].
Furthermore, the surface area of two phospholipids’ head groups is about 140 A˚2 and
DOTAP carries a single positive charge. From the requirement for charge neutrality of
the complexes it follows that the number of nucleotides (one negative charge) equals the
number of DOTAP molecules. The in vitro mRNA used here is about 1200 nucleotides
long therefore a complex carries on average
m =
2d3
65 · 140 A˚3 · 1200
= 130− 510 (5.11)
3Note that FCS can also be used to measure the concentration difference between two samples. Here
the difference between free mRNA and lipoplexes is 17nM/1.1nM = 15 which would imply that lipoplexes
carry on average 15 mRNA molecules. This however is misleading because such low sample concentrations
are not in the linear regime of FCS.
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Figure 5.9: A) Autocorrelation curve of freely diffusing mRNA labeled with Sybr Gold. B)
Autocorrelation curve after complexation with lipofectamine. The hydrodynamic radius
of the complexes is 46nm− 70nm (8nm for free mRNA). C) Cationic liposomes that are
complexed with nucleic acids assume a shape which exhibits alternating layers of nucleic
acids and lipid bilayers with a repeat distance of 65 A˚. Charge neutrality of a complex
demands that the single negative charge of each nucleotide is compensated by the single
positive charge of a DOTAP head group. Here it is assumed that 50% of all lipids in
lipofectamine are charged therefore the surface area of one positive charge is 140 A˚2.
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mRNA molecules depending on its size. Here d is the edge length of the complex and
the factor two stems from the fact both leaflets of the lipid bilayers need to be considered.
Therefore the value of 300 mRNA molecules per lipoplex obtained from the fit in Fig. 5.8
seems reasonable.
5.7 Discussion
Various cell lines were transfected with pDNA and mRNA. Universal behavior was found for
both transfection systems: onset times of pDNA transfected cells were widely distributed
and eGFP expression kinetics did not fall upon a master curve after normalization and
shifting by ton. Onset times of mRNA transfected cells on the other hand were narrowly
centered at two hours after transfection and expression kinetics followed a master curve.
A simple rate equation model for GFP synthesis of pDNA and mRNA transfected
cells was developed. The model captures the dynamics in the case of mRNA transfection
accurately but it fails to reproduce the steep rise of GFP levels in pDNA transfection
when using meaningful fit parameter values. On the other hand in chapter 4 it is shown
that this ODE model is fully capable of reproducing the kinetics of GFP transcription
and translation in a cell-free system. It can therefore be theorized that the discrepancy to
the data in living cells stems from the time delay that arises from the mRNA leaving the
nucleus prior to translation initiation as well as some form of cooperativity effects which
are not implemented in the model. A comparison of the kinetic rate constants for the
cell-free system studied in chapter 4 and the transfected A549 cells is given in Tab. 5.2.
The fact that the dynamics of mRNA translation are well captured shows that the ansatz
of using a deterministic ODE model is in principle valid for this kind of question. Further
investigation will have to be made in order to reveal the exact detail in which the current
model oversimplifies the transcription step. In this regard a simplified model system of the
gene expression mechanism in living cells like it is realized by cell-free systems may be an
invaluable tool. For example Noireaux et al. showed how cell-free systems can be enclosed
in cell like compartments. They studied compartmentalized gene expression in a cell-free
system by encapsulating the system in lipid vesicles as well as by immobilizing DNA in
dense brushes on a substrate [7, 107].
The mRNA model described here is a convenient tool for the determination of the
number of mRNAs taken up by a cell as well as the mRNA degradation rate. It proved
to be robust in the fitting procedure, that is no adjustment of initial values of the fit
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cell-free system A549 cells
transcription rate 11h−1 180h−1
translation rate 1h−1 100h−1
mRNA degradation rate 4.7 · 10−2 h−1 5.6 · 10−2 h−1
GFP degradation rate 0 5.1 · 10−2 h−1
DNA/mRNA 10−1 − 104 102
Table 5.2: Comparison of kinetic parameters and DNA/mRNA content of PURExpress cell-
free system and A549 cells obtained from data fitting as described in the text. Polymerases
and ribosomes work one to two orders of magnitude slower in vitro than they do in vivo.
For the estimation of the number of DNA/mRNA molecules in cell-free system the volume
of a A549 cell was estimated to be 10 pl.
parameters or constraint of the fit interval was necessary for individual GFP traces. It can
therefore be readily incorporated into automated data analysis. This way the model may
prove useful for quantitative studies of translation such as in gene silencing or epigenetics.
Furthermore, a stochastic model for the delivery of lipid/mRNA complexes to the
cytoplasm of a cell was developed. The model assumes that there are two bottleneck
processes in the delivery: the number of complexes taken up by one endosome and the
number of endosomes that lyse. This model with two independent consecutive Poisson
processes fits the transfection probability as a function of dose unlike a simpler model with
only one bottleneck process. It should be a convenient tool for the quick calculation of the
expected fraction of transfected cells when planning mRNA transfection measurements.
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Chapter 6
Cell-free gene expression in heavy
water
The content of this chapter is the subject of manuscript [M2].
6.1 Effects of heavy water on gene expression
So far a mathematical rate equation model of gene expression has been presented. This
modeling ansatz adequately reproduces protein synthesis in vitro. An adaption of this
ansatz was applied to an in vivo system, albeit here the transcription step had to be
omitted in order to receive satisfying results from the model. It is further of interest
how the behavior of the in vitro system changes when a small disturbance is introduced.
Using deuterium oxide instead of normal water falls into this category because its physical
properties are slightly different from ordinary H2O (Fig. 6.1 A, see also section 2.5 for
details). Especially interesting about heavy water as a disturbance is that it affects all
steps of the gene expression process. The sum of these individual disturbances is then
reflected in the overall variation of protein synthesis (Fig. 6.1 B).
The differences between H2O and D2O can be classified into two categories: the “solvent
isotope effect” (SIE) and the “kinetic isotope effect” (KIE) [108]. The SIE is due to the
properties of D2O as a solvent, i. e. its higher viscosity and density at 20
◦C compared
to H2O. The KIE is due to its slightly different chemical bonds. This effect is much more
pronounced in hydrogen than in other elements because its isotope deuterium is twice as
heavy as protium. In other elements the mass difference is only a small percentage of the
element’s mass.
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Figure 6.1: A) Deuterated water has slightly different physical properties from normal
water. This affects all steps of protein synthesis: transcription, translation and maturation.
B) The overall effect of deuteration on GFP synthesis arises from the combination of the
effects on the individual steps.
The potentials of protium bonds and deuterium bonds have basically the same shape.
The fundamental vibrational frequency of such chemical bonds follows from Hook’s law
and is given by
ν =
1
2pic
√
k
µ
(6.1)
where k is the force constant and µ the reduced mass [76]. According to quantum mechanics
the n-th energy state of a harmonic oscillator is given by
En = hν
(
n+
1
2
)
. (6.2)
From this follows that deuterium bonds have lower zero-point energy and conversely require
a higher activation energy in order to be broken. This energy difference is about 1.2 −
1.5 kcal/mol. Note that even at room temperature about 99% of all bonds are in the
zero-point state. With this it can be shown that the KIE for deuterium and protium is
with good approximation:
kH
kD
= e(hνH−hνD)/2RT (6.3)
where kH and kD are reaction rates and R is the gas constant. At room temperature (25
◦C)
this results in kH/kD ≈ 7 for C–H bonds [76].
From these observations immediately the question arises how living organisms are af-
fected when exposed to deuterium oxide. Gilbert Lewis was the first to successfully purify
deuterium oxide in 1933 and also the first to study its biological effects [75, 109, 110]. He
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found that tobacco seeds did not sprout at all in samples containing pure deuterium oxide
and respectively sprout considerably slower in samples containing 50% deuterium oxide
than in light water. Mice and rats that were given deuterium oxide as drinking water died
after seven days when the D2O concentration in their body reached 50% and 90% D2O
was reported to be lethal for fish, tadpoles and drosophila [108, 111–113]. A difference in
smell or taste between heavy water and light water is not discernable by humans. Rats
however will avoid drinking heavy water if given the choice [114]. On the intracellular level
D2O was found to affect protein structure, functionality and folding kinetics, microtubule
formation, mitosis and heat resistivity of the cellular membrane and cytoskeleton [115].
However, the effect of heavy water on gene expression kinetics has still not been elu-
cidated in detail. This point is of interest for two reasons: First, heavy water could
potentially be used as an ingredient of anti cancer therapy. It was demonstrated that
D2O hampers human tumor growth in animal models [116, 117] and represses prolifera-
tion in prokaryotes and eukaryotes [118, 119]. It is of interest to determine how far this
is due to an effect on protein synthesis. Second, NMR studies which provide the bulk of
our knowledge of protein structures require deuteration of proteins for enhanced contrast
[77, 120, 121]. Deuterated proteins are usually produced in bacterial cultures. New insights
into the impact of D2O on the cell-free gene expression mechanism might help to improve
yield strategies in cell-free systems.
Here the effect of D2O on the individual steps comprising gene expression, transcription,
translation and protein maturation was studied in vitro using GFP expression in a cell-free
system. The overall effect of D2O on protein synthesis was also measured in E. coli in order
to compare the results of the in vitro system with the in vivo value.
6.2 Experimental results
First, the overall effect of D2O on GFP synthesis in the PURE cell-free system was studied.
Samples were prepared by mixing PURE kit with DNA and filling up with a D2O/H2O
mix to the desired total concentration of D2O. In order to achieve high D2O concentrations
it was necessary to dilute samples of cell-free kit more than it is recommended by the
manufacturer. This resulted in a greatly reduced GFP yield. For this reason samples
could only be diluted to a point where close to 60% of the total sample volume consisted
of D2O. Data were recorded fluorescently on a plate reader. Fig. 6.2 shows GFP synthesis
rate and total yield in the cell-free system as a function of D2O concentration. As can be
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Figure 6.2: A) Exemplary curves of the kinetics of GFP synthesis in a cell-free system as
a function of D2O concentration; B) relative synthesis rate and C) relative final yield. The
red line represents a linear fit to the data and was inserted to help guide the eye.
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Figure 6.3: A) Proliferation and B) GFP synthesis rate of E. coli samples in M63 medium
with various D2O concentrations. Both proliferation and protein expression are inhibited
by D2O. However the inhibitory effect on GFP expression is less pronounced than in the
in vitro system.
seen D2O inhibits GFP synthesis in the in vitro system. Both parameters decrease linearly
with increasing D2O content. At the maximum possible D2O concentration in the samlpes
(about 60%) the synthesis rate and total yield of GFP were reduced by half the maximum
value. Note that the observed reduction of fluorescence shown here and in the following
figures is not due to D2O affecting the fluorophores. This was verified by comparative
analysis of fluorophore (GFP and Sybr Green mentioned further below) spectra in D2O
and H2O.
In the next step the results gained from the in vitro system were compared with those
for a living organism. Living cells feature a much more complex composition of molecules
and also exhibit feedback mechanisms as part of the gene expression machinery. E. coli
was put in M63 minimal medium containing various concentrations of D2O and cellular
proliferation and GFP synthesis were measured on a plate reader using brightfield and
fluorescence settings respectively. Fig. 6.3 A shows that D2O inhibits bacterial growth as
described in previous literature. Fig. 6.3 B depicts the effect of D2O on bacterial GFP
synthesis. The inhibitory effect is less pronounced than in the in vitro system, dropping
to about 80% in the fully deuterated medium.
A big advantage of the in vitro system is that it is possible to readily study the individual
steps of the gene expression process as described in previous chapters. The effect of D2O
on transcription was measured as follows: cell-free expression was conducted for 4h at
various D2O concentrations. Then the synthesized mRNA was purified and used to produce
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Figure 6.4: The effect of D2O on GFP transcription, translation and maturation was
measured independently in the cell-free system. A) Threshold cycle and B) the result-
ing transcription efficiency. C) Kinetics of translation and D) the resulting translation
efficiency. E) Kinetics of maturation and F) the resulting maturation rates.
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Figure 6.5: The PURE system contains T7 RNA polymerase which is a viral polymerase.
For a comparison Taq DNA polymerase was used as a model prokaryotic polymerase. A)
shows the threshold cycle and B) the resulting DNA amplification rate as a function of
D2O. Contrary to the effect seen with T7 RNA polymerase (Fig. 6.4 A, B) here D2O leads
to an inhibition of the synthesis rate.
cDNA using a reverse transcriptase protocol. The amount of synthesized cDNA is linearly
dependent on the amount of template mRNA. Subsequently a real-time PCR was executed
to determine the amount of cDNA and therewith mRNA template. The result of the PCR
measurements is depicted in Fig. 6.4 A, B (for details on the interpretation of real-time
PCR data see section 3.7). Interestingly the data do not show an inhibitory effect of D2O
on cell-free transcription but instead an increase of the transcriptional efficiency by a factor
of about two. Real-time PCR melting curves were verified to not show primer dimers.
In this regard it was also checked if D2O affects mRNA degradation: purified mRNA was
put in H2O and D2O respectively, heated to 37
◦C and left standing for 3h. Afterwards
cDNA was produced by reverse transcription and the respective amount of cDNA was
determined by real-time PCR. No D2O effect on RNAse activity was detected (data not
shown).
In order to study the effect on translation mRNA was expressed in cell-free system
and purified. Subsequently this mRNA was used as template in fresh samples of cell-free
system containing various concentrations of D2O. GFP synthesis was measured fluores-
cently on a plate reader (Fig. 6.4 C, D). The GFP synthesis rate decreases with increasing
concentrations of D2O until 40% D2O in the sample. At this point the data suggest that
the synthesis rate reaches a plateau at about half its maximum value.
Previous literature describes that D2O can affect protein folding, therefore GFP mat-
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krelsyn 0.5 [Fig. 6.2 B]
krelts 2.4 [Fig. 6.4 B]
kreltl 0.5 [Fig. 6.4 D]
krelmat 0.7 [Fig. 6.4 F]
Table 6.1: Modified reaction rates in a PURE cell-free system with 60% D2O. k
rel
syn denotes
the total relative GFP synthesis rate and krelts , k
rel
tl , k
rel
mat denote relative rates for tran-
scription, translation and maturation respectively. Here krelsyn is not simply the product of
krelts and k
rel
tl because in the PURE system there is an abundance of transcribed mRNA
compared to available ribosomes (compare Fig. 4.5). Note that the decreased maturation
rate does not result in less GFP being synthesized but simply in a longer maturation time.
Therefore the effect of D2O on GFP synthesis observed in Fig. 6.2 B corresponds to the
effect on translation and krelsyn ≈ kreltl .
uration was measured independently. As already described in section 4.2 the antibiotic
chloramphenicol was added to samples of cell-free system 2h after start to deactivate the
ribosomes. Residual increase in GFP fluorescence after this point is due to maturation (see
Fig. 6.4 E, F). GFP maturation is slowed down from 0.22min−1 in light water to about
0.13min−1 in 60% deuterated water.
The PURE cell-free system contains the viral polymerase of the T7 bacteriophage.
One can assume that the effect of D2O on transcription is focused on the participating
polymerase. In order to compare in vitro results with those for E. coli shown above
it is therefore of interest to test a prokaryotic polymerase. Taq DNA polymerase from
thermophilus aquaticus is a prokaryotic polymerase used for in vitro cDNA synthesis in
PCR. The effect of D2O was studied by preparing real-time PCR samples with the same
amount of cDNA template but various concentrations of D2O. The results are shown in
Fig. 6.5. Unlike with T7 RNA polymerase a strong inhibitory effect was found. At 70%
D2O in the samples the cDNA amplification rate approaches zero. The melting curves did
not indicate mispaired primers.
6.3 Discussion
Heavy water affects chemical reactions in living organisms due to its slightly different
physical properties compared to light water. Here the effect of D2O on the individual
steps of protein synthesis was studied in an in vitro system of purified components based
on the gene expression system of E. coli. It was found that the inhibitory effect on cell-
free GFP synthesis is linearly dependent on the concentration of D2O. Comparison with
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GFP expression in E. coli showed that the inhibitory effect is less pronounced in vivo.
This indicates that living organisms possess some sort of compensation mechanism which
makes them less susceptible to such perturbations.
Looking at the transcription step it was found that D2O leads to enhanced efficiency of
T7 RNA polymerase. At the first glance this seems to contradict the observed overall inhi-
bition of GFP synthesis: translation is a downstream process of transcription. Inhibition
of translation alone should not be enough to counteract an increased transcriptional effi-
ciency. However, as shown in section 4.2 there is an overproduction of mRNA compared
to the amount of ribosomes in the PURE system. Therefore an increase of the mRNA
amount through D2O does not result in more GFP as long as the ribosomes are saturated
anyway. Furthermore a cell-free kit is an artificial system and it is imaginable that in such
an environment D2O produces a different effect than in vivo. What is more the results
gained with Taq polymerase suggest that the target of D2O in the transcription step is
the participating polymerase and that different polymerases are affected differently. Apart
from the polymerases the remaining ingredients are nearly identical in the measurements
shown in Fig. 6.4 A, B and Fig. 6.5. Still D2O amplifies mRNA synthesis by T7 RNA
polymerase and inhibits DNA synthesis by Taq DNA polymerase. The observed inhibi-
tion of cell-free translation by D2O matches the observed inhibition of the complete gene
expression process reasonably well (table 6.1).
The results of this work suggest that D2O could be used as part of a cancer therapy
since it can hamper the expression of vital proteins in cells. Cancer cells would be especially
susceptible to this effect because of their increased metabolism. However, for this it would
be necessary to find a method to transfer D2O specifically into cancer cells in a human
body. Another consequence of this work is probably of more immediate practical use:
deuterated proteins like they are necessary for NMR studies can be readily synthesized in
a cell-free system. Protein synthesis in cell-free systems is generally much less cumbersome
and quicker than it is in cell cultures while still yielding viable amounts of protein. In this
study the cell-free kit had to be diluted in D2O in order to achieve high concentrations.
This negatively affected the performance of the system and therewith the protein yield.
Therefore the maximum attainable D2O concentration was restricted to 60%. However, if a
cell-free system which itself is dissolved in D2O was available 100% concentration would be
possible. It was found that it does take longer for GFP to maturate in D2O but that it still
folds correctly. As described in section 2.4.2 GFP maturation is an autocatalytic reaction
that is it does not involve molecular chaperons. It has to be tested if such chaperons work
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in a deuterated cell-free system in order to synthesize such proteins that require their help
to fold correctly. The insights on the effect of D2O on the individual steps of protein
synthesis gained here might help to improve yields of deuterated protein.
Putting H2O instead of D2O into the samples can be interpreted as a small perturbation
that globally affects all constituents of the gene expression reaction. It is interesting to note
that the in vivo system, although much more complex, is more robust to this perturbation
than the in vitro system. This might be due to some sort of regulatory mechanism that
helps cells to adapt to changes in environmental conditions. Identifying this mechanism
would be of fundamental theoretical interest and could also help to improve cell-free systems
as an in vitro model platform.
Chapter 7
Cell-free expression of
transmembrane protein ephrin-B2
Part of this chapter is the subject of publication [P1] (reproduced by permission of World
Scientific Publishing Company).
7.1 The role of membrane proteins
In some synthetic biology approaches to the construction of an artificial minimal cell small
volumes of cell-free expression system are encapsulated in lipid vesicles. In order to enable
nutrient uptake, waste removal, signaling or binding to a substrate it is necessary to ex-
pand such “proto-cells” with integral membrane proteins. However, cell-free expression of
membrane proteins is usually problematic. So far cell-free expression of soluble proteins,
specifically GFP, was discussed. However, about 25% of the proteome are membrane pro-
teins and as such they possess a lipophilic part (the part that incorporates into the lipid
bilayer) in their structure. They are therefore not soluble and tend to form aggregates in
solution. Furthermore, over-expressed membrane proteins tend to misfold and the yield is
low [12]. For this reason structural and functional studies of membrane proteins are still
scarce [122]. This is a matter of great concern because membrane proteins are important
components of many cellular processes and they are the target of about half of all current
pharmaceutical drugs [123, 124].
In recent years experimental strategies were developed with which correctly folded
membrane proteins can be synthesized in cell-free systems. Membrane proteins can be ex-
pressed as a precipitate in a cell-free system and solubilized afterwards using a detergent.
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It is further possible to add the detergent at the beginning of protein synthesis which yields
already solubilized proteins [125]. A third method is to carry out the expression in the
presence of an artificial lipid membrane system which is advantageous for certain appli-
cations. It has been reported that membrane proteins expressed in a cell-free system can
integrate into lipid membranes in situ and fold correctly [10–12, 124, 126–128]. However,
so far this method is not guaranteed to work for all membrane proteins and has to be
tested for each protein species individually. One also needs to consider that proteins which
require posttranslational modifications like glycosylation can not be expressed in contem-
porary cell-free systems (compare the respective paragraph in section 2.1.1). Incorporating
membrane proteins into artificial lipid membranes has possible applications in the creation
of artificial carrier systems: colloidal mesoporous silica (CMS) nanoparticles coated with a
lipid bilayer were recently proposed as a core-shell type system that can store a drug in its
interior and deliver it to a cell [129]. The lipid membrane prevents premature escape of the
agent. Incorporating the proper signaling molecules into that membrane might facilitate
cellular uptake or even enable delivery to specific cells. In the context of synthetic biology
an artificial lipid vesicle with membrane proteins incorporated into its lipid bilayer is a
first step on the way to creating an artificial cell.
It is also important to note that the role of the cellular membrane can not simply be
reduced to some two-dimensional fluid in which the membrane proteins diffuse freely. Over
the last few decades the understanding emerged that membranes exhibit a heterogeneous
composition which plays an important role in the spatial arrangement of membrane ad-
hering proteins [130]. Specifically, depending on the local lipid composition, membranes
posses a varying local thickness and can deform in three dimensions. This property has
been studied in detail in model membrane systems. It was found that the local membrane
curvature is determined by a competition between the bending rigidity of lipid domains
and minimization of the line tension along their boundaries [131, 132]. This opens up
the possibility to manipulate the lateral organization of lipid domains with a suitably mi-
crostructured substrate [133, 134]. In extension this also applies to the proteins adhering
to this membrane. In this manner it is for example possible to create well defined cellular
binding regions on top of a biologically favorable surface, namely a lipid bilayer.
In this chapter it is shown how cell-free expression was used to synthesize a fusion pro-
tein of the integral membrane protein ephrin-B2 and GFP. The expression was carried out
in the presence of model membranes and ephrin:GFP successfully incorporated into these
membranes. This work has to different future applications in mind: first, lipid vesicle en-
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Figure 7.1: Ephrin-B2 is a transmembrane protein that interacts with the EphB class of
receptor proteins. It plays a role in cell-cell signaling for axonal growth or cell migra-
tion. Ephrin-B2 has a single transmembrane region as well as a PDZ binding domain at
its cytosolic C-terminus. The N-terminus carries the receptor binding domain with a hy-
drophobic motif that fits into a cleave in the receptor’s binding domain. For this study a
fusion protein was created in which GFP was attached to the C-terminus of ephrin-B2.
capsulated cell-free system that expresses and successfully incorporates a transmembrane
protein is one step in the construction of a more advanced artificial cell. Second, incorpo-
ration of a binding protein like ephrin-B2 into a supported bilayer shall be used in future
work for the construction of defined cellular binding spots. In addition, spatial organiza-
tion of lipid domains in substrate bound model membranes by suitably microstructured
substrates is demonstrated.
7.2 Ephrin-B2
Ephrins are a family of membrane proteins that play important roles in cell adhesion,
migration and segmentation. Ephrins act as ligands for the Eph receptor family of receptor
tyrosine kinases (see Fig. 7.1). The ephrin protein family can be subdivided into two
classes, ephrin-A and ephrin-B. The five members of the ephrin-A class bind to the cellular
membrane via a glycosylphosphatidylinositol (GPI) anchor and do not posses a cytoplasmic
domain. The ephrin-B class has three members. They exhibit a single transmembrane
domain as well as a cytoplasmic PDZ domain1. For this study a fusion protein of ephrin-
B2 and GFP at its C-terminus was created. Previous work shows that such a fusion
protein is functional, that is both the ephrin-B2 and the GFP part fold correctly [135].
The complete sequence and vector map of the ephrin:GFP fusion protein is shown in the
appendix.
1PDZ domains are common protein interaction sites found in a variety of proteins.
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Figure 7.2: Measurement of ephrin:GFP bound to a membrane coated colloidal mesoporous
silica (CMS) nanoparticle using FCCS. A) The observed cross-correlation indicates that
ephrin:GFP (green GFP fluorescence) is incorporated into the membrane (red Atto 633
fluorescence). From the relatively small value of the cross-correlation follows that only a
fraction of the ephrin:GFP is incorporated whereas the remainder diffuses independently
of the nanoparticles. B) Here the data shown in (A) were scaled to 1 at the plateau of the
correlation function at 3−5ms. C) Negative control: signal of CMS nanoparticles without
ephrin:GFP. Note that due to hardware constraints of the correlation unit the correlation
curves could not be measured longer than shown here. The long diffusion times are most
likely due to optical trapping.
7.3 Cell-free expression of ephrin-B2
Ephrin:GFP incorporation was conducted in the presence of two different artificial mem-
brane systems: small unilamellar vesicles (SUVs) and CMS nanoparticles coated with a
lipid membrane. SUVs were fabricated with various diameters (100nm, 200nm and 1µm)
and consisting of various lipid compositions (egg-PC, chol/bSM/DOPC, chol/DOPC and
chol/DOPC/DOTAP). CMS nanoparticles with a diameter of 100nm were labeled with the
fluorescent dye Atto 633 and subsequently coated with a lipid bilayer membrane consisting
of the phospholipid DOPC. SUVs or nanoparticles respectively were added to the PURE
cell-free system and ephrin:GFP was expressed in their presence (compare section 3.8 for
the exact experimental protocol). Initially FCS was tried to confirm that ephrin:GFP
bound to the SUVs’ membrane. However, it was found that the average hydrodynamic ra-
dius (established via equation (3.5)) was only 30nm instead of the expected 100nm SUV
radius. This result implies that at least a considerable part of the ephrin:GFP did not
incorporate into the membranes. Instead it agglomerated in clusters which on average had
a smaller size than the SUVs. This is not unexpected as it was reported in previous work
that a good portion of membrane protein thus expressed does not successfully incorporate
into a membrane (see for example [10, 12]). In order to corroborate the incorporation of
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Figure 7.3: Fluorescence microscopy measurements of SUVs with ephrin:GFP performed
with a 100× objective. A) Agglomeration of ephrin:GFP on the bottom of the sam-
ple chamber in fluorescence and B) bright field. C) Ruptured SUVs with incorporated
ephrin:GFP in fluorescence and D) bright field. Scale bars are 2µm.
ephrin:GFP into the artificial membranes the cross correlation signal of ephrin:GFP and
Atto 633 labeled nanoparticles was measured with Fluorescence Cross Correlation Spec-
troscopy (FCCS). In the case of SUVs Texas Red/GFP cross correlation and in the case of
CMS nanoparticles Atto 633/GFP cross correlation was measured using the Two-Photon
FCS setup. The measured cross correlation amplitude is markedly smaller than the corre-
lation amplitudes of the red and green channel (Fig. 7.2 A, B). This result suggests that
part of the ephrin:GFP did indeed incorporate into the artificial membrane system. Cross
talk between the red and green channel was excluded as explanation for the observed cross
correlation (Fig. 7.2 C).
Ephrin:GFP incorporation into artificial membranes was further verified using fluo-
rescence microscopy. SUVs with a diameter of 1µm were fabricated with the extrusion
method. Individual SUVs of this size can be visualized with a 100× objective. Cell-free
expression of ephrin:GFP was performed in the presence of SUVs of 1µm diameter com-
prised of chol/DOPC/DOTAP 30:69:1. After three hours of expression at 37◦C the sample
was examined in a ibidi VI slide (poly-l-lysine treated) with a fluorescence microscope (Fig.
7.3). Freely diffusing SUVs with incorporated ephrin:GFP could not be observed. This
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Figure 7.4: A) Lo (dark) and Ld (bright) domains are almost completely separated by
the substrate induced energy barriers. Lo domains are trapped over the smooth stripes
whereas Ld domains accumulate over the rough ones. Here the domains are completely
immobile. B)-E) show a time series of trapped but still mobile Lo domains. The domains
grow until they touch the edges of the strip. At this point the domains elongate along
the energy barriers (the edges) until the line tension overcomes the attraction between
GUV and substrate. Subsequently the GUV is locally lifted from the substrate and the Lo
domains become circular again. Scale bars are 4µm.
is most likely caused by the overall low concentration of expressed ephrin:GFP. Therefore
only ephrin:GFP immobilized on the bottom of the slide could be observed. Numerous
sedimented agglomerations of ephrin:GFP were found (Fig. 7.3 A, B) as well as numer-
ous lipid patches of burst SUVs which clearly exhibited ephrin:GFP incorporation (Fig.
7.3 C, D).
It is possible that ephrin:GFP did not incorporate into SUV and nanoparticle mem-
branes in its correctly folded, that is functional form. In future work antibody labeling
will be used to corroborate this point.
7.4 Lateral organization of lipid domains on microstruc-
tured surfaces
One major aim of cell-free ephrin-B2 expression as shown here is to develop a reliable and
convenient method for the fabrication of defined cellular binding sites on a substrate. In
the following it will be shown that a microstructured substrate can lead to lateral alignment
of coexisting lipid phases in a substrate adhering membrane. Membrane proteins with a
7.4 Lateral organization of lipid domains on microstructured surfaces 89
Figure 7.5: A) Schematics of a GUV on top of a substrate with grooves. The insert shows
LSM images of the plane of the plateaus (top) and the grooves (bottom): the membrane
is uniformly located in the plane of the plateaus meaning that it spans over the grooves.
B) Schematics of a GUV on top of a SLB coated substrate. Only part of the contact area
of the GUV is drawn. Streptavidin can be used to increase the interaction force between
GUV and SLB. C) Lo domain alignment and deformation in a GUV on top of a BSA
coated substrate (no SLB). D) Lo alignment but no deformation in a GUV on top of a
SLB coated substrate (no streptavidin). Illumination disturbs the lipid domains and leads
to Lo domain coalescence and subsequent outflow from the bottom area of the GUV (E).
F)-H) Time series of nearly perfect domain separation and alignment in a GUV on top of a
substrate with SLB and streptavidin. Lo domains remain mobile. Schematic cross section
on the bottom. Scale bars are 4µm.
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preference for one of the lipid phases can thus be arranged in a defined pattern.
Giant unilamellar vesicles (GUVs) comprised of chol/bSM/DOPC 20:40:40 were pre-
pared using the electroformation method (compare section 3.8). The lipid DHPE carrying
the dye Texas Red was added to the composition in concentrations lower than one mole
percent for visualization under a fluorescence microscope. Membranes with this lipid com-
position exhibit two coexisting domains at room temperature which are distinguished by
the degree of order of their phospholipids’ tails. These phases are therefore termed “liq-
uid ordered” (Lo) and “liquid disordered” (Ld) respectively. Cholesterol predominantly
accumulates in the Lo phase whereas TR-DHPE accumulates in the Ld phase. Thus the
coexisting phases can be differentiated by fluorescence [136, 137]. Glass substrates were
microstructured with a stripe pattern of alternating smooth and rough surfaces using stan-
dard reactive ion etching methods as described in section 3.9. A cover layer of the protein
bovine serum albumin (BSA) was applied to the substrates before measurements to prevent
GUVs from rupturing when they sedimented. Sedimentation occurred due to the higher
density of the sucrose solution inside the GUVs compared to the glucose solution outside.
Lipid phases on the bottom of sedimented GUVs arranged according to the stripe pattern
(Fig. 7.4). Lo domains were trapped over the smooth regions and started to accumulate
and coalesce whereas Ld accumulated over the rough regions. In some cases the trapped Lo
domains were found to be completely immobilized (Fig. 7.4 A) whereas in others they re-
tained their mobility (Fig. 7.4 B-E). In the latter case the growing domain elongated along
the pattern boundary until the line tension overcame the energy barrier. Thereby the GUV
membrane was locally detached from the substrate and the domain became circular again.
Lipid phase demixing was also achieved with substrates that featured a micro pattern
of grooves instead of rough and smooth stripes (Fig. 7.5 A). Sedimented GUVs freely span
over the grooves due to the large hight to width aspect ratio of the micro pattern. This
was controlled with laser scanning microscopy as shown in the inlet in Fig. 7.5 A: the GUV
membrane is located in the plane of the plateaus whereas in the plane of the grooves only
light scattering is detected. On these substrates the surface was passivated either with a
BSA layer as mentioned above or with a supported lipid bilayer (SLB). The SLB could be
functionalized with streptavidin to increase the binding strength between the GUVs and
the substrate (Fig. 7.5 B). In all cases the Lo domains remained fluid and accumulated and
elongated in the freely suspended membrane parts over the grooves. In GUVs atop of BSA
passivated substrates (Fig. 7.5 C) and atop of SLB coated substrates without streptavidin
(Fig. 7.5 D-E) the substrate induced energy barrier was small. Continued illumination
7.5 Discussion 91
disturbed elongated Lo domains and they adopted a circular shape and diffused out of
the contact area. In the case of GUVs atop of SLB covered substrates with streptavidin
the energy barrier was significantly higher and the lipid domains arranged precisely along
the groove edges Fig. (7.5 F). If the interaction between GUV and the streptavidin layer
became too strong the GUV membrane was dragged down into the grooves and the Lo
domain was pressed out (see arrows in Fig. 7.5 G-H and the cartoon below). Note that
the streptavidin layer was bound to the SLB via biotinylated lipids whereas the interaction
between GUVs and streptavidin was non-specific. It was found that even very low con-
centrations of biotinylated lipids in the GUVs increased the interaction thus that GUVs
quickly ruptured.
7.5 Discussion
Cell-free expression systems can readily be used to synthesize a wide variety of soluble
proteins. However, the synthesis of membrane proteins is still no trivial matter and special
protocols have to be followed to achieve correct folding and adequate yields. This is the case
for both cellular as well as cell-free expression. For this study a fusion protein of ephrin-B2
and GFP was constructed and expressed in cell-free system in the presence of artificial
lipid membranes. Using two complimentary methods it is shown that ephrin:GFP most
likely incorporated into the membranes: with FCCS for freely diffusing vesicles and with
fluorescence microscopy for vesicles immobilized on a substrate. Control measurements
using antibody labeling need yet to be done to ensure this point.
Incorporating the proper receptor molecules into the lipid membrane surrounding a
CMS nanoparticle could facilitate cellular uptake and enable targeting of specific cell types.
This might have great potential for example in anti cancer therapies were such nanoparticles
could be used as drug ferries. Vesicles with incorporated membrane proteins are a ready
model platform for the development of an artificial minimal cell, a major goal of synthetic
biology research.
A major goal of this project is to use ephrin incorporated into a SLB to create binding
sites for cells. Especially with regard to automated measurements it is important to create
a defined pattern of such binding sites. That is ephrin anchors should only accumulate in
specific regions of the substrate. Here it is shown that microstructures on a substrate can
induce alignment and deformation of coexisting lipid phases in adhering membranes. This
could be used as a possible sorting mechanism for membrane proteins with a preference
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for a specific lipid phase. Apart from the static patterning approach described here a
remarkable alternative would be to use an active substrate to create ephrin patterns. It
was shown that surface acoustic waves (SAWs) can be used to create reversible patterns
of SLB bound macromolecules [138, 139]. An interesting application for example would
be to use propagating SAWs to create a density gradient of ephrin and to study cellular
behavior under such conditions.
Chapter 8
Outlook
The thesis at hand concerns cell-free gene expression as a biophysical model system for the
intricate protein synthesis reactions of living cells. Cell-free systems are dilutions of the
minimal components of the cellular transcription and translation machinery which allow
biochemical synthesis of specific target proteins in vitro. The main objective of this thesis
was to quantitatively study gene expression kinetics in vitro and to create a predictive
mathematical model of these kinetics. Measurements were carried out fluorescently on a
micro plate array which permits real-time read-out and parallelization. Due to sample
volumes of a few micro liters all components were present in high copy numbers therefore
stochastic noise was insignificant. Such a properly characterized in vitro model system in
combination with a stringent mathematical modeling is a valuable tool for studies of tran-
scription and translation mechanics, gene interaction networks, modifications of individual
reaction components as well as the construction of artificial cellular structures.
To this end a quantitative and predictive rate equation model of the cell-free protein
synthesis kinetics was developed. The model accurately fits time courses of mRNA as well
as protein synthesis from beginning to end. This was achieved by taking into account finite
resources as well as degradation of the cell-free machinery over time. In order to check how
far this completely artificial system can be compared to one that more closely resembles the
situation in vivo a similar modeling approach was applied to the GFP synthesis kinetics
of mRNA and DNA transfected cells respectively. It was found that the time courses of
mRNA transfected cells but not DNA transfected cells can be fitted with this basic ansatz.
This finding hints at a mechanism in cellular gene expression, possibly mRNA transport
from the nucleus to the cytosol or some sort of cooperativity, that is so far not completely
understood. Comparative studies with an in vitro model might help to elucidate this
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Figure 8.1: A) Cell-free expression can be readily combined with microfluidics chips. Here
the schematics of a chip that was developed at the chair is shown. The quadratic sample
chambers have a volume of 0.1nl each. They could be filled with 1− 104 DNA or mRNA
molecules for cell-free expression depending on the respective concentration. A second
layer of channels (drawn in blue) atop the first one can be used as valve that seals the in-
and outlets of the chambers. B) Lipid vesicles filled with cell-free system can be used as a
platform for the construction of an artificial minimal cell. Especially the extension of this
concept to transmembrane proteins would be interesting. This would for example allow to
emulate cellular nutrient uptake in vitro.
point: cell-free kits are basically a modular system and they could be expanded with new
functionalities like compartmentalization, an expression network with several stages [5] or
feedback loops.
In this regard it would be of great interest to reliably measure the kinetics of mRNA
and protein synthesis simultaneously. Molecular beacons as applied in this thesis reli-
ably label mRNA but they also impede translation because ribosomes can not process
mRNA/molecular beacon hybrids. This problem could be solved by using the new RNA
aptamers introduced by Paige et al. [85] (compare section 3.5). Adding the aptamer se-
quence to the GFP sequence on the mRNA both transcription and translation kinetics
could be visualized simultaneously.
One of the big advantages of cell-free gene expression is that it can be readily downscaled
and combined with microfluidics. In this thesis the typical sample volume was of the order
of ten micro liters. Various microfluidics approaches were tested to downscale the sample
volume (down to nano liters) but this resulted in significant loss of signal to noise. However,
this was most likely due to deviations in the filling of the nano wells used here (compare
section 3.3). It should be possible to avoid this problem with a more advanced microfluidics
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setup like the one described by Maerkl et al. [18] or a chip that was recently developed at
the chair (Fig. 8.1 A). These chips exhibit a two story layout of the microfluidics channels
where the upper channels can be used as valves that seal the sample volumes. Such
chips would allow for a massive increase in measurement parallelization on the order of
hundreds of parallel samples instead of only about ten. A further point of interest that
could be studied using small volumes as described here (0.1nl) would be stochasticity in
gene expression due to low copy numbers of participating components. Depending on the
concentration of the DNA used it is possible to fill such volumes with only one DNA or
mRNA molecule each. Single molecule sensitivity on the fluorescence microscope would
be necessary [140, 141] to measure the exact number of synthesized mRNAs or proteins
respectively.
Furthermore, with such a microfluidics chip the unpacking mechanics of complexed
DNA, specifically polyethylenimine (PEI) complexed DNA could be studied. PEI is a
cationic polymer that is used in transfection. So far it is not completely understood
how exactly the complexed DNA is processed by the cell, that is if it is unpacked or if
polymerases manage to transcribe complexed DNA. This could be elucidated with cell-free
expression: unpacking would become noticeable as a step function in the GFP fluorescence
as more and more DNA molecules become accessible. Processing of complexed DNA on the
other hand should be verifiable by a simple decrease in the transcription rate compared to
free DNA. Especially for the verification of the first case working with small copy numbers
and massive parallelization using microfluidics would most likely be necessary. Some bulk
experiments were performed in the course of this thesis but it was not possible to distinguish
the two cases from these results alone.
The creation of a synthetic minimal cell is a long standing goal of synthetic biology.
Encapsulation of a cell-free system inside a vesicle is one approach to this end. Such en-
capsulation methods were tested successfully in the course of this thesis but not further
pursued. This was because the focus shifted to the point that all samples should have
the same volume in order to make parallel quantitative measurements of the GFP syn-
thesis kinetics. However, it would probably be interesting to pursue this approach for
transmembrane proteins like ephrin-B2 as well as nutrient uptake proteins or membrane
pore proteins. This way an artificial cell could be created that could be immobilized on a
substrate, be fed from the environment and release its waste products (Fig. 8.1 B).
Miniaturization, automatization and “lab on a chip” are typical keywords which are
often used to describe the expected future development of current laboratory methods. In
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the course of this process the importance of cell-free expression systems can be expected
to grow further as they suit these requirements well.
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Appendix B
Ephrin-B2:GFP sequence and vector
map
LOCUS dna 5409 bp
FEATURES Location/Qualifiers
Promoter 21..39
/gene="T7 prom"
misc_binding 98..103
/dbxref="REBASE:NdeI"
other_gene 100..1172
/gene="EFNB2"
Tag 101..133
/gene="T7_leader tag"
Other Gene 101..133
/gene="T7_gene10_leader other"
ORF 101..1909
/sequence="ORF_1 rf(2)"
misc_binding 136..141
/dbxref="REBASE:BamHI"
misc_binding 142..147
/dbxref="REBASE:KpnI"
misc_binding 250..255
/dbxref="REBASE:ClaI"
misc_binding 491..496
/dbxref="REBASE:EcoRV"
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Reporter 1190..1906
/gene="EGFP reporter"
misc_binding 1911..1918
/dbxref="REBASE:NotI"
misc_binding 1920..1925
/dbxref="REBASE:XhoI"
misc_binding 1920..1925
/dbxref="REBASE:AvaI"
misc_binding 1920..1925
/dbxref="REBASE:AvrI"
Terminator 1954..2082
/gene="T7 term"
Rep_Origin 2111..2417
/gene="f1 origin"
Promoter 2611..2639
/gene="amp prom"
Marker 2681..3541
/gene="amp marker"
ORF 2681..3541
/sequence="ORF_2 rf(2)"
misc_binding 3222..3227
/dbxref="REBASE:PstI"
misc_binding 3344..3354
/dbxref="REBASE:BglI"
Rep_Origin 3696..4315
/gene="pBR322 origin"
misc_binding 3942..3950
/dbxref="REBASE:AlwNI"
misc_binding 4587..4592
/dbxref="REBASE:AccI"
Other Gene 4730..4921
/gene="ROP other"
misc_binding 4767..4772
/dbxref="REBASE:PvuII"
BASE COUNT 1360 a 1422 c 1386 g 1241 t 0 others
ORIGIN
1 agatctcgat cccgcgaaat taatacgact cactataggg agaccacaac ggtttccctc
101
61 tagaaataat tttgtttaac tttaagaagg agatatacat atggctagca tgactggtgg
121 acagcaaatg ggtcgggatc cggtaccgag gagatctgcc gccgcgatcg ccatggctgt
181 gagaagggac tccgtgtgga agtactgctg gggtgttttg atggttttat gcagaactgc
241 gatttccaaa tcgatagttt tagagcctat ctattggaat tcctcgaact ccaaatttct
301 acctggacaa ggactggtac tatacccaca gataggagac aaattggata ttatttgccc
361 caaagtggac tctaaaactg ttggccagta tgaatattat aaagtttata tggttgataa
421 agaccaagca gacagatgca ctattaagaa ggaaaatacc cctctcctca actgtgccaa
481 accagaccaa gatatcaaat tcaccatcaa gtttcaagaa ttcagcccta acctctgggg
541 tctagaattt cagaagaaca aagattatta cattatatct acatcaaatg ggtctttgga
601 gggcctggat aaccaggagg gaggggtgtg ccagacaaga gccatgaaga tcctcatgaa
661 agttggacaa gatgcaagtt ctgctggatc aaccaggaat aaagatccaa caagacgtcc
721 agaactagaa gctggtacaa atggaagaag ttcgacaaca agtccctttg taaaaccaaa
781 tccaggttct agcacagacg gcaacagcgc cggacattcg gggaacaaca tcctcggttc
841 cgaagtggcc ttatttgcag ggattgcttc aggatgcatc atcttcatcg tcatcatcat
901 cacgctggtg gtcctcttgc tgaagtaccg gaggagacac aggaagcact cgccgcagca
961 cacgaccacg ctgtcgctca gcacactggc cacacccaag cgcagcggca acaacaacgg
1021 ctcagagccc agtgacatta tcatcccgct aaggactgcg gacagcgtct tctgccctca
1081 ctacgagaag gtcagcgggg actacgggca cccggtgtac atcgtccagg agatgccccc
1141 gcagagcccg gcgaacattt actacaaggt cacgcgtccg gtcgccacca tggtgagcaa
1201 gggcgaggag ctgttcaccg gggtggtgcc catcctggtc gagctggacg gcgacgtaaa
1261 cggccacaag ttcagcgtgt ccggcgaggg cgagggcgat gccacctacg gcaagctgac
1321 cctgaagttc atctgcacca ccggcaagct gcccgtgccc tggcccaccc tcgtgaccac
1381 cctgacctac ggcgtgcagt gcttcagccg ctaccccgac cacatgaagc agcacgactt
1441 cttcaagtcc gccatgcccg aaggctacgt ccaggagcgc accatcttct tcaaggacga
1501 cggcaactac aagacccgcg ccgaggtgaa gttcgagggc gacaccctgg tgaaccgcat
1561 cgagctgaag ggcatcgact tcaaggagga cggcaacatc ctggggcaca agctggagta
1621 caactacaac agccacaacg tctatatcat ggccgacaag cagaagaacg gcatcaaggt
1681 gaacttcaag atccgccaca acatcgagga cggcagcgtg cagctcgccg accactacca
1741 gcagaacacc cccatcggcg acggccccgt gctgctgccc gacaaccact acctgagcac
1801 ccagtccgcc ctgagcaaag accccaacga gaagcgcgat cacatggtcc tgctggagtt
1861 cgtgaccgcc gccgggatca ctctcggcat ggacgagctg tacaagtaaa gcggccgcac
1921 tcgagcacca ccaccaccac cactgagatc cggctgctaa caaagcccga aaggaagctg
1981 agttggctgc tgccaccgct gagcaataac tagcataacc ccttggggcc tctaaacggg
2041 tcttgagggg ttttttgctg aaaggaggaa ctatatccgg attggcgaat gggacgcgcc
2101 ctgtagcggc gcattaagcg cggcgggtgt ggtggttacg cgcagcgtga ccgctacact
2161 tgccagcgcc ctagcgcccg ctcctttcgc tttcttccct tcctttctcg ccacgttcgc
2221 cggctttccc cgtcaagctc taaatcgggg gctcccttta gggttccgat ttagtgcttt
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2281 acggcacctc gaccccaaaa aacttgatta gggtgatggt tcacgtagtg ggccatcgcc
2341 ctgatagacg gtttttcgcc ctttgacgtt ggagtccacg ttctttaata gtggactctt
2401 gttccaaact ggaacaacac tcaaccctat ctcggtctat tcttttgatt tataagggat
2461 tttgccgatt tcggcctatt ggttaaaaaa tgagctgatt taacaaaaat ttaacgcgaa
2521 ttttaacaaa atattaacgt ttacaatttc aggtggcact tttcggggaa atgtgcgcgg
2581 aacccctatt tgtttatttt tctaaataca ttcaaatatg tatccgctca tgagacaata
2641 accctgataa atgcttcaat aatattgaaa aaggaagagt atgagtattc aacatttccg
2701 tgtcgccctt attccctttt ttgcggcatt ttgccttcct gtttttgctc acccagaaac
2761 gctggtgaaa gtaaaagatg ctgaagatca gttgggtgca cgagtgggtt acatcgaact
2821 ggatctcaac agcggtaaga tccttgagag ttttcgcccc gaagaacgtt ttccaatgat
2881 gagcactttt aaagttctgc tatgtggcgc ggtattatcc cgtattgacg ccgggcaaga
2941 gcaactcggt cgccgcatac actattctca gaatgacttg gttgagtact caccagtcac
3001 agaaaagcat cttacggatg gcatgacagt aagagaatta tgcagtgctg ccataaccat
3061 gagtgataac actgcggcca acttacttct gacaacgatc ggaggaccga aggagctaac
3121 cgcttttttg cacaacatgg gggatcatgt aactcgcctt gatcgttggg aaccggagct
3181 gaatgaagcc ataccaaacg acgagcgtga caccacgatg cctgcagcaa tggcaacaac
3241 gttgcgcaaa ctattaactg gcgaactact tactctagct tcccggcaac aattaataga
3301 ctggatggag gcggataaag ttgcaggacc acttctgcgc tcggcccttc cggctggctg
3361 gtttattgct gataaatctg gagccggtga gcgtgggtct cgcggtatca ttgcagcact
3421 ggggccagat ggtaagccct cccgtatcgt agttatctac acgacgggga gtcaggcaac
3481 tatggatgaa cgaaatagac agatcgctga gataggtgcc tcactgatta agcattggta
3541 actgtcagac caagtttact catatatact ttagattgat ttaaaacttc atttttaatt
3601 taaaaggatc taggtgaaga tcctttttga taatctcatg accaaaatcc cttaacgtga
3661 gttttcgttc cactgagcgt cagaccccgt agaaaagatc aaaggatctt cttgagatcc
3721 tttttttctg cgcgtaatct gctgcttgca aacaaaaaaa ccaccgctac cagcggtggt
3781 ttgtttgccg gatcaagagc taccaactct ttttccgaag gtaactggct tcagcagagc
3841 gcagatacca aatactgtcc ttctagtgta gccgtagtta ggccaccact tcaagaactc
3901 tgtagcaccg cctacatacc tcgctctgct aatcctgtta ccagtggctg ctgccagtgg
3961 cgataagtcg tgtcttaccg ggttggactc aagacgatag ttaccggata aggcgcagcg
4021 gtcgggctga acggggggtt cgtgcacaca gcccagcttg gagcgaacga cctacaccga
4081 actgagatac ctacagcgtg agctatgaga aagcgccacg cttcccgaag ggagaaaggc
4141 ggacaggtat ccggtaagcg gcagggtcgg aacaggagag cgcacgaggg agcttccagg
4201 gggaaacgcc tggtatcttt atagtcctgt cgggtttcgc cacctctgac ttgagcgtcg
4261 atttttgtga tgctcgtcag gggggcggag cctatggaaa aacgccagca acgcggcctt
4321 tttacggttc ctggcctttt gctggccttt tgctcacatg ttctttcctg cgttatcccc
4381 tgattctgtg gataaccgta ttaccgcctt tgagtgagct gataccgctc gccgcagccg
4441 aacgaccgag cgcagcgagt cagtgagcga ggaagcggaa gagcgcctga tgcggtattt
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4501 tctccttacg catctgtgcg gtatttcaca ccgcatatat ggtgcactct cagtacaatc
4561 tgctctgatg ccgcatagtt aagccagtat acactccgct atcgctacgt gactgggtca
4621 tggctgcgcc ccgacacccg ccaacacccg ctgacgcgcc ctgacgggct tgtctgctcc
4681 cggcatccgc ttacagacaa gctgtgaccg tctccgggag ctgcatgtgt cagaggtttt
4741 caccgtcatc accgaaacgc gcgaggcagc tgcggtaaag ctcatcagcg tggtcgtgaa
4801 gcgattcaca gatgtctgcc tgttcatccg cgtccagctc gttgagtttc tccagaagcg
4861 ttaatgtctg gcttctgata aagcgggcca tgttaagggc ggttttttcc tgtttggtca
4921 ctgatgcctc cgtgtaaggg ggatttctgt tcatgggggt aatgataccg atgaaacgag
4981 agaggatgct cacgatacgg gttactgatg atgaacatgc ccggttactg gaacgttgtg
5041 agggtaaaca actggcggta tggatgcggc gggaccagag aaaaatcact cagggtcaat
5101 gccagcgctt cgttaataca gatgtaggtg ttccacaggg tagccagcag catcctgcga
5161 tgcagatccg gaacataatg gtgcagggcg ctgacttccg cgtttccaga ctttacgaaa
5221 cacggaaacc gaagaccatt catgttgttg ctcaggtcgc agacgttttg cagcagcagt
5281 cgcttcacgt tcgctcgcgt atcggtgatt cattctgcta accagtaagg caaccccgcc
5341 agcctagccg ggtcctcaac gacaggagca cgatcatgcg cacccgtggc caggacccaa
5401 cgctgcccg
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